Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 29, 2024 | Jun. 30, 2023 | |
Cover [Abstract] | |||
Entity Registrant Name | SOBR SAFE, INC. | ||
Entity Central Index Key | 0001425627 | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Entity Voluntary Filers | No | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well Known Seasoned Issuer | No | ||
Entity Small Business | true | ||
Entity Shell Company | false | ||
Entity Emerging Growth Company | false | ||
Entity Current Reporting Status | Yes | ||
Document Period End Date | Dec. 31, 2023 | ||
Entity Filer Category | Non-accelerated Filer | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2023 | ||
Entity Common Stock Shares Outstanding | 20,007,465 | ||
Entity Public Float | $ 31,525,769 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Fin Stmt Error Correction Flag | false | ||
Entity File Number | 000-53316 | ||
Entity Incorporation State Country Code | DE | ||
Entity Tax Identification Number | 26-0731818 | ||
Entity Address Address Line 1 | 6400 S. Fiddlers Green Circle | ||
Entity Address Address Line 2 | Suite 1400 | ||
Entity Address City Or Town | Greenwood Village | ||
Entity Address State Or Province | CO | ||
Entity Address Postal Zip Code | 80111 | ||
City Area Code | 844) | ||
Local Phone Number | 762-7723 | ||
Security 12b Title | Common Stock, $0.00001 par value | ||
Trading Symbol | SOBR | ||
Security Exchange Name | NASDAQ | ||
Entity Interactive Data Current | Yes | ||
Auditor Name | Haynie and Company | ||
Auditor Location | Littleton, Colorado | ||
Auditor Firm Id | 457 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash | $ 2,790,147 | $ 8,578,997 |
Accounts receivable, net | 25,280 | 30,322 |
Inventory | 342,782 | 215,493 |
Prepaid expenses | 213,261 | 200,905 |
Total current assets | 3,371,470 | 9,025,717 |
Intellectual technology, net | 2,473,429 | 2,858,893 |
Operating lease right-of-use assets | 274,713 | 0 |
Other assets | 27,427 | 27,427 |
Total Assets | 6,147,039 | 11,912,037 |
Current liabilities | ||
Accounts payable | 525,665 | 142,965 |
Accrued expenses | 726,940 | 392,282 |
Accrued interest payable | 96,988 | 469,691 |
Related party payables | 0 | 1,887 |
Operating lease liabilities, current portion | 97,108 | 0 |
Notes payable - related parties, net | 11,810 | 866,262 |
Notes payable - non-related parties, net | 64,331 | 948,597 |
Total current liabilities | 1,522,842 | 2,821,684 |
Operating lease liabilities, less current portion | 203,295 | 0 |
Notes payable - non-related parties-less current portion, net | 2,305,898 | 0 |
Accrued interest payable | 132,467 | 0 |
Total Liabilities | 4,164,502 | 2,821,684 |
Stockholders' Equity (Deficit) | ||
Preferred stock, value | 0 | 0 |
Common stock, $0.00001 par value; 100,000,000 shares authorized; 18,582,241 and 16,984,570 shares issued and outstanding including shares held in treasury at December 31, 2023 and December 31, 2022, respectively | 186 | 170 |
Treasury stock, at cost; 12,329 as of December 31, 2023 and December 31, 2022 | (38,015) | (38,015) |
Additional paid-in capital | 89,840,017 | 87,509,666 |
Accumulated deficit | (87,765,981) | (78,327,845) |
Total SOBR Safe, Inc. stockholders' equity (deficit) | 2,036,207 | 9,144,006 |
Noncontrolling interest | (53,670) | (53,653) |
Total Stockholders' Equity (Deficit) | 1,982,537 | 9,090,353 |
Total Liabilities and Stockholders' Equity (Deficit) | 6,147,039 | 11,912,037 |
Series A one Convertible Preferred stock [Member] | ||
Stockholders' Equity (Deficit) | ||
Preferred stock, value | 0 | 0 |
Series A Convertible Preferred stock [Member] | ||
Stockholders' Equity (Deficit) | ||
Preferred stock, value | 0 | 0 |
Series B Convertible Preferred [Member] | ||
Stockholders' Equity (Deficit) | ||
Preferred stock, value | $ 0 | $ 30 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Treasury stock, at cost | 12,329 | 12,329 |
Common stock, shares par value | $ 0.00001 | $ 0.00001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 18,582,241 | 16,984,570 |
Common stock, shares outstanding | 18,582,241 | 16,984,570 |
Preferred stock, shares par value | $ 0.00001 | $ 0.00001 |
Preferred stock, shares authorized | 16,300,000 | 16,300,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Series A one Convertible Preferred stock [Member] | ||
Preferred stock, shares par value | $ 0.00001 | $ 0.00001 |
Preferred stock, shares authorized | 2,700,000 | 2,700,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Series A Convertible Preferred stock [Member] | ||
Preferred stock, shares par value | $ 0.00001 | $ 0.00001 |
Preferred stock, shares authorized | 3,000,000 | 3,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Series B Convertible Preferred stock | ||
Preferred stock, shares par value | $ 0.00001 | $ 0.00001 |
Preferred stock, shares authorized | 3,000,000 | 3,000,000 |
Preferred stock, shares issued | 0 | 3,000,000 |
Preferred stock, shares outstanding | 0 | 3,000,000 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
CONSOLIDATED STATEMENTS OF OPERATIONS | ||
Revenues | $ 157,292 | $ 35,322 |
Cost of goods sold | 94,942 | 19,315 |
Gross profit | 62,350 | 16,007 |
Operating expenses: | ||
General and administrative | 6,400,723 | 6,024,001 |
Stock-based compensation expense | 2,245,871 | 3,008,395 |
Research and development | 1,016,302 | 1,397,053 |
Total operating expenses | 9,662,896 | 10,429,449 |
Loss from operations | (9,600,546) | (10,413,442) |
Other income (expense): | ||
Other income | 216,211 | 230,414 |
Gain (loss) on debt extinguishment, net | (26,125) | 245,105 |
Gain on fair value adjustment - derivatives | 0 | 1,040,000 |
Interest expense | (804,261) | (3,457,007) |
Total other expense, net | (614,175) | (1,941,488) |
Loss before provision for income taxes | (10,214,721) | (12,354,930) |
Provision for income taxes | 0 | 0 |
Net loss | (10,214,721) | (12,354,930) |
Net loss attributable to noncontrolling interest | 17 | 17 |
Net loss attributable to SOBR Safe, Inc. | (10,214,704) | (12,354,913) |
Deemed dividends related to underwritten public offering warrants down round provision | 0 | (5,005,857) |
Deemed dividends related to Original Warrants and New Warrant down round provision | 0 | (3,495,583) |
Net loss attributable to common stockholders | $ (10,214,704) | $ (20,856,353) |
Basic and diluted loss per common share | $ (0.56) | $ (1.90) |
Weighted average number of common shares outstanding | 18,147,830 | 11,003,049 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) | Total | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-In Capital | Retained Earnings (Accumulated Deficit) | Stockholders Deficit SOBR Safe Inc [Member] | Noncontrolling Interest | Treasury Stock |
Balance, shares at Dec. 31, 2021 | 8,778,555 | |||||||
Balance, amount at Dec. 31, 2021 | $ (483,593) | $ 0 | $ 88 | $ 57,041,447 | $ (57,471,492) | $ (429,957) | $ (53,636) | $ 0 |
Common stock issued for restricted stock units vested, shares | 191,919 | |||||||
Common stock issued for restricted stock units vested, amount | 2 | 0 | $ 2 | 0 | 0 | 2 | 0 | 0 |
Common stock issued for convertible debt, shares | 7,917 | |||||||
Common stock issued for convertible debt, amount | 47,500 | $ 0 | $ 0 | 47,500 | 0 | 47,500 | 0 | 0 |
Common stock exchanged for convertible preferred stock, shares | 3,000,000 | (1,000,000) | ||||||
Common stock exchanged for convertible preferred stock, amount | 0 | $ 30 | $ (10) | (20) | 0 | 0 | 0 | 0 |
Additional common stock issued upon reverse stock split, shares | 1,012 | |||||||
Additional common stock issued upon reverse stock split, amount | 0 | 0 | $ 0 | 0 | 0 | 0 | 0 | 0 |
Common stock and warrants issued in public equity offering, net of issuance costs, shares | 2,352,942 | |||||||
Common stock and warrants issued in public equity offering, net of issuance costs, amount | 8,694,363 | 0 | $ 24 | 8,694,339 | 0 | 8,694,363 | 0 | 0 |
Common stock and warrants issued in private equity offering, net of issuance costs, shares | 1,925,677 | |||||||
Common stock and warrants issued in private equity offering, net of issuance costs, amount | 5,121,973 | 0 | $ 19 | 5,121,954 | 0 | 5,121,973 | 0 | 0 |
Common stock issued upon exercise of stock warrants, net of issuance costs, shares | 3,775,942 | |||||||
Common stock issued upon exercise of stock warrants, net of issuance costs, amount | 3,328,143 | 0 | $ 38 | 3,328,105 | 0 | 3,328,143 | 0 | 0 |
Common stock issued upon exercise of stock options, shares | 48,106 | |||||||
Common stock issued upon exercise of stock options, amount | 38,015 | 0 | $ 0 | 38,015 | 0 | 38,015 | 0 | $ 0 |
Purchase of treasury stock, shares | (12,329) | |||||||
Purchase of treasury stock, amount | (38,015) | 0 | $ 0 | 0 | 0 | (38,015) | 0 | $ (38,015) |
Common stock issued for services, shares | 902,500 | |||||||
Common stock issued for services, amount | 864,500 | 0 | $ 9 | 864,491 | 0 | 864,500 | 0 | 0 |
Paid-in capital - fair value of stock options and restricted stock units vested | 3,008,395 | 0 | 0 | 3,008,395 | 0 | 3,008,395 | 0 | 0 |
Paid in capital - relative fair value of stock warrants granted | 864,000 | 0 | 0 | 864,000 | 0 | 864,000 | 0 | 0 |
Deemed dividends related to underwritten public offering warrants down round provision | 0 | 0 | 0 | 5,005,857 | (5,005,857) | 0 | 0 | 0 |
Deemed dividends related to Original Warrants and New Warrant down round provision | 0 | 0 | 0 | 3,495,583 | (3,495,583) | 0 | 0 | 0 |
Net loss | (12,354,930) | $ 0 | $ 0 | 0 | (12,354,913) | (12,354,913) | (17) | $ 0 |
Balance, shares at Dec. 31, 2022 | 3,000,000 | 16,984,570 | 12,329 | |||||
Balance, amount at Dec. 31, 2022 | 9,090,353 | $ 30 | $ 170 | 87,509,666 | (78,327,845) | 9,144,006 | (53,653) | $ (38,015) |
Common stock issued for restricted stock units vested, shares | 235,000 | |||||||
Common stock issued for restricted stock units vested, amount | 0 | 0 | $ 3 | (3) | 0 | 0 | 0 | 0 |
Common stock issued for services, shares | 225,000 | |||||||
Common stock issued for services, amount | 211,500 | 0 | $ 2 | 211,498 | 0 | 211,500 | 0 | 0 |
Paid-in capital - fair value of stock options and restricted stock units vested | 2,245,871 | 0 | 0 | 2,245,871 | 0 | 2,245,871 | 0 | 0 |
Net loss | (10,214,721) | 0 | 0 | 0 | (10,214,704) | (10,214,704) | (17) | 0 |
Cumulative effect of adopting ASU 2020-06 | (132,646) | 0 | 0 | (909,214) | 776,568 | (132,646) | 0 | 0 |
Warrants issued for services | 162,481 | 0 | 0 | 162,481 | 0 | 162,481 | 0 | 0 |
Paid-in capital - relative fair value of stock warrants granted, net of issuance costs | 398,517 | $ 0 | $ 0 | 398,517 | 0 | 398,517 | 0 | 0 |
Conversion of preferred stock to common stock, shares | (3,000,000) | 1,000,000 | ||||||
Conversion of preferred stock to common stock, amount | 0 | $ (30) | $ 10 | 20 | 0 | 0 | 0 | 0 |
Common stock issued upon conversion of convertible debt, shares | 150,000 | |||||||
Common stock issued upon conversion of convertible debt, amount | 221,182 | 0 | $ 1 | 221,181 | 0 | 221,182 | 0 | $ 0 |
Balance, shares at Dec. 31, 2023 | 18,594,570 | 12,329 | ||||||
Balance, amount at Dec. 31, 2023 | $ 1,982,537 | $ 0 | $ 186 | $ 89,840,017 | $ (87,765,981) | $ 2,036,207 | $ (53,670) | $ (38,015) |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating Activities: | ||
Net loss | $ (10,214,721) | $ (12,354,930) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of intangible assets | 385,464 | 385,464 |
Amortization of debt discounts | 562,690 | 2,295,586 |
(Gain) loss on debt extinguishment | 26,125 | (245,105) |
Change in fair value of derivative liability | 0 | (1,040,000) |
Stock-based compensation expense | 2,245,871 | 3,008,395 |
Stock issued for professional services | 0 | 864,500 |
Non-cash interest expense | 29,638 | 0 |
Non-cash lease expense | 55,994 | 0 |
Bad debt expense | 3,124 | 0 |
Changes in assets and liabilities: | ||
Accounts receivable | 1,918 | (30,322) |
Inventory | (127,289) | (176,032) |
Prepaid expenses | 655,507 | 86,238 |
Other assets | 0 | 3,148 |
Accounts payable | 382,700 | (127,185) |
Accrued expenses | 334,658 | 1,037,486 |
Accrued interest payable | (237,564) | 217,581 |
Related party payables | (1,887) | (80,996) |
Operating lease liabilities | (30,304) | 0 |
Net cash used in operating activities | (5,928,076) | (6,156,172) |
Financing Activities: | ||
Proceeds from notes payable - non-related parties | 3,000,001 | 0 |
Repayments of notes payable - non-related parties | (1,323,025) | (242,797) |
Repayments of notes payable - related parties | (1,000,000) | 0 |
Debt issuance costs | (537,750) | 0 |
Proceeds from public equity offering | 0 | 10,004,245 |
Cost of public equity offering | 0 | (1,309,882) |
Proceeds from private equity offering | 0 | 5,997,873 |
Cost of private equity offering | 0 | (875,900) |
Proceeds from exercise of stock warrants, net | 0 | 3,328,143 |
Repayments of convertible debenture payable | 0 | (3,048,781) |
Net cash provided by financing activities | 139,226 | 13,852,901 |
Net Change In Cash | (5,788,850) | 7,696,729 |
Cash At The Beginning Of The Period | 8,578,997 | 882,268 |
Cash At The End Of The Period | 2,790,147 | 8,578,997 |
Schedule Of Non-Cash Investing And Financing Activities: | ||
Issuance of common stock and warrants for prepaid services | 373,981 | 0 |
Non-related party debt converted to capital | 341,998 | 47,500 |
Operating lease right-of-use assets and liabilities | 330,707 | 0 |
Financing of prepaid insurance premiums | 293,882 | (274,589) |
Conversion of preferred stock to common stock | 30 | 0 |
Conversion of common stock to preferred stock | 0 | 30 |
Deemed dividends related to underwritten public offering warrants down round provision | 0 | 5,005,857 |
Deemed dividends related to Original Warrants and New Warrant down round provision | 0 | 3,495,583 |
Derecognition of convertible debenture | 0 | 3,048,781 |
Reacquisition value of convertible debenture | 0 | (3,912,781) |
Fair value of shares issued for services | 0 | (719,000) |
Exchange of common shares from exercise of stock options | 0 | 38,015 |
Reclassification of common shares from reverse stock split | 0 | 155 |
Supplemental Disclosure: | ||
Cash paid for interest | 446,069 | 30,722 |
Cash paid for income taxes | $ 0 | $ 0 |
ORGANIZATION OPERATIONS AND SUM
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2023 | |
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 1. ORGANIZATION, OPERATIONS, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SOBR Safe, Inc., a Delaware corporation, (the “Company”, “we”, “us”, and “our”) is a hardware and software company headquartered in Greenwood Village, Colorado. Our company integrates proprietary software with our patented touch-based alcohol detection products, SOBRcheck™ and SOBRsure™, enabling non-invasive alcohol detection, biometric identity verification, and real-time cloud-based alerts and reporting. Currently our principal markets are located in North America. On May 16, 2022, our common stock began trading on the Nasdaq exchange under the ticker symbol “SOBR.” Prior to this, our common stock was quoted on the “OTCQB” tier of the OTC Markets, also under the ticker symbol “SOBR.” Basis of Presentation The accompanying audited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for the presentation of annual financial information. In management’s opinion, the audited consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at December 31, 2023 and December 31, 2022, and results of operations and cash flows for the years ended December 31, 2023 and December 31, 2022. Principles of Consolidation The accompanying audited consolidated financial statements include the accounts of the Company and its majority-owned subsidiary, TransBiotec-CA, of 98.6%. We have eliminated all intercompany transactions and balances between entities consolidated in these audited financial statements. Use of Estimates The preparation of audited consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates. Financial Instruments The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The fair value hierarchy is based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company prioritizes the inputs into three levels that may be used to measure fair value: Level Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist primarily of cash, accounts receivable, accounts payable, accrued expenses, accrued interest payable, related party payables, notes payable, and other liabilities. The Company believes that the recorded values of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. At December 31, 2023 and December 31, 2022, the Company did not have financial instruments requiring valuation from observable or unobservable inputs to determine fair value on a recurring basis. Cash The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of December 31, 2023 and December 31, 2022. Accounts Receivable Customer accounts are monitored for potential credit losses based upon management’s assessment of expected collectability and the allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration any circumstances of which the Company is aware regarding a customer’s inability to meet its financial obligations to the Company, and any potential prevailing economic conditions and their impact on the Company’s customers. The Company had $982 in allowance for doubtful accounts and no allowance for doubtful accounts at December 31, 2023 and December 31, 2022, respectively. Inventory Inventory is comprised of component parts and finished product and is valued at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. The Company evaluates the valuation of inventory and periodically adjusts the value for estimated excess based upon estimates of future demand and market conditions, and obsolete inventory based upon otherwise damaged or impaired goods. The Company had no reserves for obsolescence at December 31, 2023 and December 31, 2022. Prepaid Expenses Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided. Beneficial Conversion Features As discussed under “Recently Adopted Accounting Standard” in Note 1, the Company adopted ASU 2020-06 effective January 1, 2023, which, among other things, eliminated the beneficial conversion feature model applicable to certain convertible instruments. Prior to the adoption of ASU 2020-06, a beneficial conversion feature existed on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount was amortized to interest expense over the life of the note using the effective interest method. Derivative Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivate instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the audited consolidated statements of operations under other income (expense). The company had no derivative instruments as of December 31, 2023. Debt Issuance Costs Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the audited consolidated balance sheet. Preferred Stock Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, the Company classifies preferred shares in stockholders’ equity. Noncontrolling Interest A subsidiary of the Company has minority members representing ownership interests of 1.4% at December 31, 2023 and December 31, 2022. The Company accounts for this noncontrolling interest whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance. Impairment of Long-Lived Assets Long-lived assets and identifiable intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. If the sum of undiscounted expected future cash flows is less than the carrying amount of the asset or if changes in facts and circumstances indicate, an impairment loss is recognized and measured using the asset’s fair value. No impairment loss was recognized during the years ended December 31, 2023 and 2022, respectively. Revenue Recognition The Company enters contracts with customers and generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services. Depending on the combination of products and services detailed in the respective customer contract, the identifiable components may be highly interdependent and interrelated with each other such that each is required to provide the substance of the value of the Company’s offering and accounted for as a combined performance obligation, or the specific components may be generally distinct and accounted for as separate performance obligations. Revenue is recognized when control of these software products and/or services are transferred to the customer in an amount that reflects the consideration the Company expects to be entitled in exchange for these respective services and devices. The Company determines revenue recognition through five steps which include (1) the identification of the contract or contracts with a customer, (2) identification of individual or combined performance obligations contained in the contract, (3) determination of the transaction price detailed within the contract, (4) allocation of the transaction price to the specific performance obligations, and (5) finally, recognition of revenue as the Company’s performance obligations are satisfied according to the terms of the contract. Contracts with a Single License/Service Performance Obligation For contracts with a single performance obligation consisting of a license and/or data services, the entire transaction price is allocated to the single performance obligation. Where the Company provides a performance obligation as licensed software or data services, revenue is recognized upon delivery of the software or services ratably over the respective term of the contract. Contracts for Purchase of Hardware Devices Only Where hardware devices are sold separately by the Company, the entire transaction price is allocated to the device as an individual performance obligation and revenue is recognized at a point in time when either legal title, physical possession or the risks and rewards of ownership have transferred to the customer. Generally, these requirements are satisfied at the point in time the Company ships the product, as this is when the customer obtains control of the asset under the Company’s standard terms and conditions of the purchase. Contracts with Multiple Performance Obligations Where a Company’s contract with a respective customer contains multiple performance obligations and due to the interdependent and interrelated nature of the licensed software, hardware devices and data reporting services, the Company accounts for the individual performance obligations if they are distinct in nature and the transaction price is allocated to each distinct performance obligations on a directly observable standalone sales price basis. Determining whether products and services are distinct performance obligations that should be accounted for separately or combined as one unit of accounting may require significant judgment. Standalone selling prices are primarily based upon the price at which the performance obligation is sold separately. The Company may be able to establish a standalone sales price based upon observable products or services sold or priced separately in comparable circumstances, competitor pricing or similar customers. Where the performance obligations are either not distinct or directly observable, the Company estimates the standalone sales price of the performance obligations based upon the overall pricing objectives taking into consideration the value of the contract arrangement, number of licenses, number and types of hardware devices and the length of term of the contract. Professional judgement may be required to determine the standalone sales price for each performance obligation where not directly observable. Revenue for Contracts with Multiple Performance Obligations is recognized on a ratable basis for each respective performance obligation as allocated under the prescribed transaction price identification model applied. The Company requires customers to make payments related to subscribed software licenses and data services on a monthly basis via authorized bank account ACH withdrawal or an automatic credit card charge during the approved term of the respective agreement. The collectability of future cash flows are reasonably assured with any potential non-payment easily identified with future services being discontinued or suspended due to non-payment. The Company’s contracts are generally twelve to thirty-six months in duration, are billed monthly in advance and are non-cancelable. The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced and a receivable is recorded. A contract asset (unbilled revenue) is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company has elected to charge shipping, freight and delivery to customers as a source of revenue to offset respective costs when control has transferred to the customer. The Company reports revenue net of sales and other taxes collected from customers to be remitted to government authorities. Estimated costs for the Company’s standard one-year warranty are charged to cost of goods and services when revenue is recorded for the related product. Royalties are also charged to cost of goods and services. Leases The Company determines if an arrangement is or contains a lease at inception. Leases with an initial term of twelve months or less are considered short-term leases and are not recognized on the Company’s audited consolidated balance sheet. Right-of-use (“ROU”) assets and liabilities are recognized on the audited consolidated balance sheet for leases with an expected term greater than twelve months. Operating lease ROU assets represent our right to use an underlying asset over the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at inception based on the present value of lease payments over the lease term. When the rate implicit in the lease is not determinable, the Company uses its estimated secured incremental borrowing rate in determining the present value of lease payments. The lease expense for fixed lease payments is recorded on a straight-line basis over the lease term and variable lease payments are included in the lease expense when the obligation for those payments is incurred. The Company has elected not to separate lease and non-lease components. Stock-based Compensation The Company uses the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants, options, and restricted stock units). The fair value of each warrant and option is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the awards. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term. The grant date fair value of a restricted stock unit equals the closing price of our common stock on the trading day of the grant date. Research and Development Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its products. Advertising and Marketing Costs Advertising and marketing costs are charged to operations as incurred. Advertising and marketing costs were $190,614 and $169,010 during the years ended December 31, 2023 and December 31, 2022, respectively. Income Tax Deferred taxes are provided on an asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at December 31, 2023 and December 31, 2022 as these have been offset by a 100% valuation allowance. Loss Per Share Basic loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted loss per share gives the effect to all dilutive potential common shares outstanding during the period, including stock options, warrants and convertible instruments. Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive. Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented. Concentration of Risk Credit Risk – Concentration of Customers Concentration of Suppliers Related Parties Related parties are any entities or individuals that, through employment, ownership or other means, possess the ability to direct or cause the direction of the management and policies of the Company. Recently Adopted Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt– Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity The Company early adopted ASU 2020-06 effective January 1, 2023, using the modified retrospective method whereby the cumulative effect of the change is recognized as an adjustment to the opening balance of retained earnings at the date of adoption. On January 1, 2023, the Company recorded an increase to retained earnings (accumulated deficit) of $776,569 and a decrease to additional paid-in capital of $909,214 to fully remove the unamortized debt discount related to beneficial conversion features of $132,646. The Company has reviewed other recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations. Reclassifications Certain prior period amounts have been reclassified to conform with the current period presentation. None of these reclassifications had a material impact on the audited consolidated financial statements. |
GOING CONCERN
GOING CONCERN | 12 Months Ended |
Dec. 31, 2023 | |
GOING CONCERN | |
GOING CONCERN | NOTE 2. GOING CONCERN The Company has incurred recurring losses from operations and has limited cash liquidity and capital resources to meet future capital requirements. The Company’s ability to meet future capital requirements will depend on many factors, including the Company’s ability to sell and develop products, generate cash flow from operations, and assess competing market developments. The Company may need additional capital resources in the near future. Sources of debt financing may result in additional interest expense. Any financing, if available, may be on unfavorable terms. If adequate funds are not available or obtained, the Company may be required to reduce or curtail operations. As of December 31, 2023, the Company has an accumulated deficit of approximately $87,800,000. During the year ended December 31, 2023, the Company also experienced negative cash flows from operating activities of approximately $5,900,000 and has $2,305,000 of convertible notes payable due in various amounts in March 2025. These principal conditions and events, when considered in the aggregate, could indicate it is probable that the Company will be unable to meet its obligations as they become due within one year after the date the financial statements are issued. However, the Company has identified factors that may mitigate the probable conditions that have raised substantial doubt about the entity’s ability to continue as a going concern. Based on an evaluation of current operating cash usage, management identified several areas in which the Company is capable to reduce spend should it be needed. This includes reductions in operating headcount, discretionary sales & marketing spend, investor relations initiatives, and product/software research and development planning. Ongoing activities to identify and reduce monthly expenses by management will continue in perpetuity until such time financial liquidity and substantial cash flow from sales are realized. Management believes the introduction of its SOBRsure TM Management believes that cash balances of approximately $2,800,000 and positive working capital of approximately $1,900,000 at December 31, 2023, do not provide adequate capital for operating activities for the next twelve months after the date these financial statements are issued. However, management believes actions presently being taken to generate product and services revenues, and positive cash flows, in addition to the Company’s plans and ability to access capital sources and implement expense reduction tactics to preserve working capital provide the opportunity for the Company to continue as a going concern as of December 31, 2023. These plans are contingent upon the actions to be performed by the Company and these conditions have not been met on or before December 31, 2023. As such, substantial doubt about the entity’s ability to continue as a going concern has not been alleviated as of December 31, 2023. |
INVENTORY
INVENTORY | 12 Months Ended |
Dec. 31, 2023 | |
INVENTORY | |
INVENTORY | NOTE 3. INVENTORY Inventory at December 31, 2023 and December 31, 2022 consisted of the following: December 31, December 31, 2023 2022 Component parts $ 59,157 $ 68,643 Finished goods 283,625 146,850 Inventory $ 342,782 $ 215,493 |
PREPAID EXPENSES
PREPAID EXPENSES | 12 Months Ended |
Dec. 31, 2023 | |
PREPAID EXPENSES | |
PREPAID EXPENSES | NOTE 4. PREPAID EXPENSES Prepaid expenses at December 31, 2023 and December 31, 2022 consisted of the following: December 31, December 31, 2023 2022 Insurance $ 156,724 $ 150,344 Deposit 15,736 15,736 Rent 16,714 - Other 24,087 34,825 Prepaid expenses $ 213,261 $ 200,905 On May 18, 2023, the Company purchased Directors & Officers insurance prepaying annual premiums of $367,352 through a eight-month financing arrangement (see Note 9). The Company recorded $9,167 of insurance expense related to the prepaid Directors & Officers insurance during the year ended December 31, 2023. |
LEASES
LEASES | 12 Months Ended |
Dec. 31, 2023 | |
LEASES | |
LEASES | NOTE 5. LEASES The Company leases its corporate headquarters office space and certain office equipment under arrangements classified as operating leases. The Company entered into its lease agreement to rent office space for a twelve-month period beginning July 1, 2022 with a monthly base rent of $9,744. The lease did not contain renewal options and was considered a short-term lease at inception. In April 2023, the Company executed an amendment to extend the term of the lease from July 1, 2023 through September 30, 2026. The amended lease provides for monthly base rent of $9,310 through September 2024, with fixed escalating monthly base rent for each year thereafter, and no rent due for the months of July through September 2023. The Company determined that the amendment results in a lease modification that is not accounted for as a separate contract. Further, due to the extension of the lease term beyond the initial twelve months, the office lease can no longer be considered a short-term lease. The Company has recorded a right-of-use asset and lease liability as of April 17, 2023 (the effective date of the amendment) based on the modified terms and conditions of the amended lease. The Company entered into a lease agreement for copier equipment in June 2023, requiring monthly lease payments of $329 through May 2026. Total operating lease expense was $180,895, which included $38,719 of variable lease expense and $65,375 of short-term lease expense during the year ended December 31, 2023. Operating lease obligations recorded on the audited consolidated balance sheet at December 31, 2023 are as follows: Operating lease liabilities, current portion $ 97,108 Operating lease liabilities – less current portion 203,295 Total Operating Lease Liabilities $ 300,403 Future lease payments included in the measurement of operating lease liabilities on the audited consolidated balance sheet at December 31, 2023 are as follows: 2024 $ 121,831 2025 125,644 2026 95,063 Total future minimum lease payments 342,538 Less imputed interest (42,135 ) Total Operating Lease Liabilities $ 300,403 The weighted average remaining lease term is 33 months, and the weighted average discount rate is 10%. |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 12 Months Ended |
Dec. 31, 2023 | |
INTANGIBLE ASSETS | |
INTANGIBLE ASSETS | NOTE 6. INTANGIBLE ASSETS Intangible assets consisted of the following at December 31, 2023: Gross Carrying Accumulated Net Intangible Amortization Period Amount Amortization Asset (in years) SOBRsafe TM $ 3,854,675 $ 1,381,246 $ 2,473,429 10 Intangible assets consisted of the following at December 31, 2022: Gross Carrying Accumulated Net Intangible Amortization Period Amount Amortization Asset (in years) SOBRsafe TM $ 3,854,675 $ 995,782 $ 2,858,893 10 Amortization expense was $385,464 for the years ended December 31, 2023 and 2022. Estimated future amortization expense for device technology intangible assets is as follows: 2024 2025 2026 2027 2028 Thereafter $ 385,464 $ 385,464 $ 385,464 $ 385,464 $ 385,464 $ 546,109 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Dec. 31, 2023 | |
RELATED PARTY TRANSACTIONS | |
RELATED PARTY TRANSACTIONS | NOTE 7. RELATED PARTY TRANSACTIONS On March 1, 2022 the Board of Directors approved the designation of 3,000,000 shares of the Company’s Preferred Stock as “Series B Convertible Preferred Stock”. The Series B Convertible Preferred Stock shares were issued in exchange for 333,333 shares of the Company’s common stock held by the Company’s CEO David Gandini and 666,667 shares of the Company’s common stock held by IDTEC SPV, LLC, an entity controlled by a beneficial owner of the Company (see Note 11). On April 20, 2023 the 3,000,000 Series B Convertible Preferred shares were converted to 1,000,000 shares of the Company’s common stock at the option of the preferred stockholders. Neither the exchange nor the conversion resulted in a transfer of value. |
ACCRUED EXPENSES
ACCRUED EXPENSES | 12 Months Ended |
Dec. 31, 2023 | |
ACCRUED EXPENSES | |
ACCRUED EXPENSES | NOTE 8. ACCRUED EXPENSES Accrued expenses at December 31, 2023 and December 31, 2022 consisted of the following: December 31, 2023 December 31, 2022 Consulting services 328,196 197,897 R&D services 220,000 - Other 178,744 194,385 Accrued expenses $ 726,940 $ 392,282 |
NOTES PAYABLE
NOTES PAYABLE | 12 Months Ended |
Dec. 31, 2023 | |
NOTES PAYABLE | |
NOTES PAYABLE | NOTE 9. NOTES PAYABLE RELATED PARTIES Related party notes payable at December 31, 2023 and December 31, 2022 consisted of the following: December 31, 2023 December 31, 2022 Convertible Notes Payable with Warrants – 2021 Debt Offering $ - $ 1,000,000 Non-Convertible Notes Payable 11,810 11,810 Unamortized Debt Discount - (145,548 ) Net Related Party Notes Payable $ 11,810 $ 866,262 Current Portion (11,810 ) (866,262 ) Net Long-Term Portion $ - $ - Total interest expense for related party notes was $27,501 and $120,000 for the years ended December 31, 2023 and 2022, respectively. Related Party Convertible Notes Payable with Warrants – 2021 Debt Offering During March, April, and May 2021, as part of a 2021 Debt Offering, the Company issued thirteen convertible notes payable to related parties with principal balances totaling $1,000,000. The notes, secured by the Company’s patents and patents applications, include interest at 12%, are convertible at $9 per share of the Company’s common stock and are due 24 months after issuance. Each of the notes was issued with detached free-standing warrants to purchase the Company’s common stock at $9 per share. The notes included interest at 12% which the noteholders could elect to have paid in cash monthly or have the interest accrue and be payable on the maturity date, if not sooner converted. The Company evaluated the convertible notes payable for embedded derivatives and beneficial conversion features and determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $448,999 is amortized over the life of the convertible notes payable. The debt discount amortization expense is recorded as amortization of interest – beneficial conversion features in the audited consolidated statements of operations and was none and $167,913 for the years ended December 31, 2023, and 2022, respectively. The unamortized debt discount related to the beneficial conversion feature was $66,843 at December 31, 2022. This balance was eliminated upon adoption of ASU 2020-06 effective January 1, 2023 (see Note 1). At the time of issuance, a portion of the proceeds from the 2021 Debt Offering was allocated to the stock warrants based on their relative fair value, resulting in a debt discount of $551,001 which was amortized over the life of the notes. Amortization of the debt discount related to the stock warrants is recorded as interest expense and was $62,837 and $275,500 for the years ended December 31, 2023, and 2022, respectively. The Company fully repaid the remaining principal and accrued interest on the notes in March and April 2023. A portion of the notes were repaid prior to their stated maturities in April and May 2023. As a result, the Company recorded a loss on debt extinguishment of $26,125 equal to the remaining unamortized debt discount on the notes at the time of repayment. Related Party Non-Convertible Note Payable The Company has one non-convertible note payable that has a principal balance of $11,810 as of December 31, 2023 and 2022. The note carries an interest rate of 0%. The note payable had a due date of December 31, 2012 and is currently in default. NON- RELATED PARTIES Notes payable to non-related parties consist of the following: December 31, 2023 December 31, 2022 Convertible Notes Payable with Warrants – 2023 Debt Offering $ 3,219,724 $ - Convertible Notes Payable with Warrants – 2021 Debt Offering - 1,005,000 Convertible Notes Payable 9,183 9,183 Non-Convertible Notes Payable 17,500 17,500 Premium Financing Note Payable 37,648 61,792 Unamortized Debt Discount (913,826 ) (144,878 ) Net Non-Related Party Notes Payable $ 2,370,229 $ 948,597 Current Portion (64,331 ) (948,597 ) Net Long-Term Portion $ 2,305,898 $ - Total interest expense for non-related party notes was $240,311 and $134,628 for the years ended December 31, 2023 and 2022, respectively. Convertible Notes Payable with Warrants – 2023 Debt Offering On March 7, 2023, the Company entered into a Debt Offering (the “2023 Debt Offering”) pursuant to a Purchase Agreement (the “Agreement”) and Registration Rights Agreement with institutional investors. The 2023 Debt Offering closed on March 9, 2023. The 2023 Debt Offering includes 15% Original Issue Discount Convertible Notes (the “Notes”) and Common Stock Purchase Warrants (the “Warrants”). Under the terms of the Agreement, the Company received $3,000,001 from the Purchasers and in exchange issued the Notes in principal amounts of $3,529,412 and Warrants to purchase up to 386,998 shares of the Company’s common stock. The Notes may be converted voluntarily by the Purchaser at any time the principal amounts are outstanding into shares of our common stock at a conversion price of $2.28. The Notes are due March 10, 2025, and accrue interest quarterly at 5% per annum. The accrued interest is compounded quarterly, payable on the maturity date, if not sooner converted. The Warrants are exercisable at any time through March 9, 2028, into shares of the Company’s common stock at an exercise price of $2.52 per share. The Company received approximately $2,500,000 of net proceeds from the 2023 Debt Offering after offering-related costs. On May 10, 2023, noteholders elected to convert a total of $341,999 (the “Conversion Amount”) pertaining to the 2023 Debt Offering into 150,000 shares of the Company’s common stock at $2.28 per share. As provided for in the Agreement, the Conversion Amount included original Note principal of $309,688, as well as accrued interest of $32,311. Convertible Notes Payable with Warrants – 2021 Debt Offering During 2021, as part of a 2021 Debt Offering, the Company issued sixteen convertible notes payable to non-related parties with principal balances totaling $1,005,000. The notes, secured by the Company’s patent applications, were convertible into the Company’s common stock at $9 per share, and were due 24 months after issuance. Each of the notes was also issued with detached free-standing warrants to purchase the Company’s common stock at $9 per share. The notes included interest at 12% which the noteholders could elect to have paid in cash monthly or have the interest accrue and be payable on the maturity date, if not sooner converted. Upon issuance, the Company evaluated the convertible notes payable for embedded derivatives and beneficial conversion features and determined that there were beneficial conversion features to record. The total beneficial conversion feature debt discount of $460,215 was being amortized over the life of the convertible notes payable. The debt discount amortization expense is recorded as amortization of interest – beneficial conversion features in the consolidated statements of operations was none and $231,353 for the years ended December 31, 2023 and 2022, respectively. The unamortized debt discount related to the beneficial conversion feature was $65,803 at December 31, 2022. This balance was eliminated upon adoption of ASU 2020-06 effective January 1, 2023 (see Note 1). At the time of issuance, a portion of the proceeds from the 2021 Debt Offering was allocated to the stock warrants based on their relative fair value, resulting in a debt discount of $541,707 which was amortized over the life of the notes. Amortization of the debt discount related to the stock warrants is recorded as interest expense and was $68,818 and $272,350 for the years ended December 31, 2023 and 2022, respectively. The Company fully repaid the remaining principal and accrued interest on the notes during 2023, prior to maturity. As a result, the Company recorded a loss on debt extinguishment of $10,257 equal to the remaining unamortized debt discount on the notes at the time of repayment. Convertible Notes Payable The Company has two convertible notes payable to a non-related entity with principal balances totaling $9,183 for the years ended December 31, 2023 and 2022, respectively. The notes bear interest at 12% and are convertible into shares of the Company’s common stock at $32.29 per share. The notes were due in 2013 and are currently in default. Non-Convertible Notes Payable The Company has two non-convertible notes payable to non-related parties with principal balances totaling $17,500 for the years ended December 31, 2023 and 2022, respectively. These notes carry interest ranging from 9% - 10% and have due dates ranging from December 2013 to November 2015. The notes are currently in default. Premium Financing Note Payable On May 25, 2022, the Company entered into a financing agreement for payment of its annual Directors & Officers insurance premiums for coverage from May 2022 through May 2023 totaling $349,455. The financing agreement required an initial down payment of $74,866 with the remaining amount of $274,559 financed for a nine-month period at an annual interest rate of 4.37% with monthly payments of $31,068 beginning in June 2022. The note was paid in full in February 2023. On June 15, 2023, the Company entered into a financing agreement for payments of its annual Directors & Officers insurance premiums for coverage from May 2023 through May 2024 totaling $367,352. The financing agreement required an initial down payment of $73,470 with the remaining amount of $293,882 financed for an eight-month period at an annual interest rate of 8.49% with monthly payments of $37,914 beginning in June 2023. The financing liability balance at December 31, 2023 was $37,648. |
COMMON STOCK
COMMON STOCK | 12 Months Ended |
Dec. 31, 2023 | |
COMMON STOCK | |
COMMON STOCK | NOTE 10. COMMON STOCK The Company’s common stock transactions for the year ended December 31, 2023 consisted of the following: The Company issued 225,000 shares of common stock to a consultant for investor relations services. The Company issued 235,000 shares of its common stock for RSUs vested during 2023. The Company issued 150,000 shares of its common stock upon conversion of a portion of the Notes issued in the 2023 Debt Offering. The Company exchanged 3,000,000 shares of Series B Convertible Preferred Stock with related parties for 1,000,000 shares of common stock (see Notes 7 and 11). The Company’s common stock transactions for the year ended December 31, 2022 consisted of the following: The Company issued 191,919 shares of its common stock for 175,252 RSUs vested during 2022 and 16,667 RSUs vested during 2021. The Company issued 7,917 shares of common stock upon conversion of a $47,500 convertible note payable. The Company exchanged 1,000,000 shares of common stock for 3,000,000 shares of Series B Convertible Preferred Stock (see Note 11). The Company issued 1,012 shares of common stock in connection with the rounding provision of the 1-for-3 reverse stock split effective in 2022. On May 18, 2022, the Company issued 2,352,942 shares of common stock in connection with a completed underwritten public offering. The Company received approximately $8,700,000 of net proceeds from the sale of 2,352,942 units (Units) at a public offering price of $4.25 per Unit, with each Unit consisting of one share of our Common Stock, and two warrants each to purchase one share of Common Stock. On September 30, 2022, the Company received approximately $5,120,000 of net proceeds from the sale of 4,054,055 PIPE units at an offering price of $1.48 per PIPE unit. In connection with the PIPE Offering, the Company issued 1,925,677 Non-Prefunded Units and 2,128,378 Prefunded Units priced at-the-market under Nasdaq rules. The Prefunded Units were sold at the same price less the Prefunded Warrant exercise price of $0.001. Each Non-Prefunded Unit consists of one share of common stock and one non-tradable Non-Prefunded Warrant exercisable for one share of common stock, at a price of $1.35, subject to adjustments pursuant to the non-prefunded warrant agreement (“Non-Prefunded Warrant Agreement”). Each Prefunded Unit consists of one share of a Non-Prefunded Warrant and one non-tradable Prefunded Warrant exercisable for one share of common stock, at a price of $1.35 less the Prefunded Warrant exercise price of $0.001, subject to adjustments pursuant to the prefunded warrant agreement (“Prefunded Warrant Agreement”). The Company issued 1,647,564 shares of its common stock under the terms of the May 2022 underwritten public offering at the stock warrant exercise price of $2.125 per share. The Company issued 2,128,378 shares of its common stock under the terms of the September 2022 PIPE offering at the Prefunded stock warrant exercise price of $0.001 per share. The Company issued 48,106 shares of its common stock at the stock options exercise price of $0.79026 per share. Proceeds from the options exercised included 12,329 shares of the Company’s previously issued common stock surrendered by the option holders and classified as Treasury Stock at December 31, 2022. The Company issued 500,000 shares of its common stock to a consultant as a prepayment for strategic advisory and digital marketing services. The common shares were issued at $0.91 per share with a fair value on the date of issuance of $455,000. The Company issued 300,000 shares of its common stock to a consultant as prepayment for business development consulting services. The common shares were issued at $0.88 per share with a fair value on the date of issuance of $264,000. The Company issued 75,000 shares of its common stock to a beneficial owner of the Company for the professional services (see Note 6). The common shares were issued at $0.94 per share with a fair value on the date of issuance of $70,500. The Company issued 27,500 shares of its common stock to a consultant as prepayment for investor relation services. The common shares were issued at $2.73 per share with a fair value on the date of issuance of $75,000. |
PREFERRED STOCK
PREFERRED STOCK | 12 Months Ended |
Dec. 31, 2023 | |
PREFERRED STOCK | |
PREFERRED STOCK | NOTE 11. PREFERRED STOCK On November 20, 2015, the Company’s Board of Directors authorized a class of stock designated as preferred stock with a par value of $0.00001 per share comprising 25,000,000 shares, 3,000,000 shares of which were classified as Series A Convertible Preferred Stock. In each calendar year, the holders of the Series A Convertible Preferred Stock are entitled to receive, when, as and if, declared by the Board of Directors, out of any funds and assets of the Company legally available, non-cumulative dividends, in an amount equal to any dividends or other Distribution on the common stock in such calendar year (other than a Common Stock Dividend). No dividends (other than a Common Stock Dividend) shall be paid and no distribution shall be made with respect to the common stock unless dividends shall have been paid or declared and set apart for payment to the holders of the Series A Convertible Preferred Stock simultaneously. Dividends on the Series A Convertible Preferred Stock shall not be mandatory or cumulative, and no rights or interest shall accrue to the holders of the Series A Convertible Preferred Stock by reason of the fact that the Company shall fail to declare or pay dividends on the Series A Convertible Preferred Stock, except for such rights or interest that may arise as a result of the Company paying a dividend or making a distribution on the common stock in violation of the terms. The holders of each share of Series A Convertible Preferred Stock then outstanding shall be entitled to be paid, out of the Available Funds and Assets, and prior and in preference to any payment or Distribution (or any setting part of any payment or Distribution) of any Available Funds and Assets on any shares of common stock, and equal in preference to any payment or Distribution (or any setting part of any payment or Distribution) of any Available Funds and Assets on any shares of any other series of preferred stock that have liquidation preference, an amount per share equal to the Original Issue Price of the Series A Convertible Preferred Stock plus all declared but unpaid dividends on the Series A Convertible Preferred Stock. A reorganization, or any other consolidation or merger of the Company with or into any other corporation, or any other sale of all or substantially all of the assets of the Company, shall not be deemed a liquidation, dissolution, or winding up of the Company. Shares of the Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share of the Corporation’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion is at least $5.01. The shares of Series A Convertible Preferred Stock vote on a one for one basis. The right of conversion is limited by the fact the holder of the Series A Convertible Preferred Stock may not convert if such conversion would cause the holder to beneficially own more than 4.9% of the Company’s common stock after giving effect to such conversion. On December 9, 2019, the Company’s Board of Directors created a class of preferred stock designated as 8% Series A-1 Convertible Preferred Stock comprising of 2,000,000 shares. During 2020, the authorized shares were increased to 2,700,000 shares. The rights and preferences of the 8% Series A-1 Convertible Preferred Stock are as follows: (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $3 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC), (d) redemption rights such that we have the right, upon 30 days written notice, at any time after one year from the date of issuance, to redeem all or part of the Series A-1 Convertible Preferred Stock for 150% of the original issuance price, (e) no call rights by the Company, and (f) each share of Series A-1 Convertible Preferred Stock will vote on an “as converted” basis. On March 1, 2022 the Board of Directors approved the designation of 3,000,000 shares of the Company’s Preferred Stock as “Series B Convertible Preferred Stock”. The Company entered into the Share Exchange Agreements to provide certain changes to its capital structure in connection with the planned underwriting offering and listing on Nasdaq. The convertible preferred stock is classified as a permanent equity instrument. The exchange of common stock for the convertible preferred stock results in no value transfer from the common shareholders to the preferred shareholders and vice versa should the preferred stock be converted back to common. The rights and preferences of the Series B Convertible Preferred Stock are as follows: (a) dividends shall not be mandatory or cumulative, (b) liquidation preference over the Company’s common stock at an amount per share equal to the original issue price of the Series B Convertible Preferred Stock plus all accrued but unpaid dividends on the Series B Convertible Preferred Stock, (c) each three shares of Series B Convertible Preferred Stock shall be convertible, at the option of the holder, beginning on the date that is six months from the date the Holder acquired the shares of Series B Convertible Preferred Stock, and without the payment of additional consideration by the holder , into one share of common stock, (d) no redemption rights by the Company, (e) no call rights by the Company, and (f) each share of Series B Convertible Preferred Stock will vote on an “as converted” basis. On April 20, 2023 the 3,000,000 Series B Convertible Preferred shares were converted to 1,000,000 shares of the Company’s common stock at the option of the preferred stockholders. Neither the exchange nor the conversion resulted in a transfer of value. |
STOCK WARRANTS STOCK OPTIONS AN
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS | 12 Months Ended |
Dec. 31, 2023 | |
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS | |
STOCK WARRANTS, STOCK OPTIONS AND RESTRICTED STOCK UNITS | NOTE 12. STOCK WARRANTS, STOCK OPTIONS AND RESTRICTED STOCK UNITS The Company accounts for share-based compensation stock options and restricted stock units, and non-employee stock warrants whereby costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable, utilizing either the Black-Scholes pricing model or the Monte Carlo simulation option pricing model for stock options and warrants, and the closing price of our common stock on the grant date for restricted stock units. Unless otherwise provided for, the Company covers equity instrument exercises by issuing new shares. Stock Warrants On March 30, 2022, the Company issued warrants to purchase up to 101,626 shares of common stock at $6 per share in exchange for a waiver of default penalties under the terms of a convertible debenture. The relative fair value of the warrants at the time of issuance was $864,000. The exercise price on the warrants was reduced to $1.35 per share in September 2022 in accordance with a down-round provision contained in the warrants. The warrants expire seven years after the date of issuance. On May 18, 2022, the Company issued through an underwritten public offering 4,705,884 Offering Warrants, 424,116 Underwriter Warrants, and 141,177 Representative Warrants to purchase common stock of the Company at exercise prices of $4.25, $4.25 and $5.3125 per share, respectively. The warrants expire five years from the date of issuance and were valued using the Monte Carlo simulation option pricing model at approximately $5,700,000. The exercise price on the Offering Warrants and Underwriter Warrants was reduced to $2.125 per share in September 2022 in accordance with a down-round provision contained in those warrants. As of December 31, 2023, 3,623,613 warrants remain outstanding. In January 2023, the Company entered into a consulting agreement for professional services to be provided over a 6-month period in exchange for the issuance of 225,000 common shares and 225,000 warrants to purchase shares of common stock at $1.35 per share. The warrants expire three years from the date of issuance. The warrants were valued at $162,481 using the Black-Scholes model on the date of issuance, which was recognized over the six-month term of the agreement. On March 9, 2023, in conjunction with the 2023 Debt Offering (see Note 9), the Company issued a total of 386,998 warrants to purchase shares of common stock at $2.52 per share. The warrants expire five years from the date of issuance. Total proceeds from the 2023 Debt Offering were allocated to the warrants based on their relative fair value, resulting in $398,517 allocated to the warrants after issuance costs. The fair value of these non-employee stock warrants granted during the years ended December 31, 2023 and 2022 totaled $560,998 and $27,540,584, respectively, and were determined using the Monte Carlo simulation and Black-Scholes option pricing models based on the following assumptions: December 31, 2023 December 31, 2022 Exercise Price $ 1.35-2.52 $ 1.35-6.00 Dividend Yield 0 % 0 % Volatility 162-209% 110-160% Risk-free Interest Rate 4.56-4.73% 2.45–4.62% Life of Warrants 3-5 Years 1-7 Years The following table summarizes the changes in the Company’s outstanding warrants during the years ended December 31, 2023 and 2022: Warrants Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2022 10,387,877 $ 1.35 -9.00 5.11 Years $ 1.56 $ - Warrants Granted 611,998 1.35-2.52 3.39 Years 2.09 - Warrants Exercised - Warrants Expired 394,167 2.56-9.00 0 Years 8.02 - Balance at December 31, 2023 10,605,708 1.35-5.31 4.59 Years 1.70 - Warrants Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2021 836,464 $ 1.50 – 9.00 3.04 Years $ 6.78 $ 1,784,838 Warrants Granted 13,375,461 $ 1.35 – 5.3125 4.38 Years $ 1.94 $ - Warrants Exercised (3,775,942 ) $ 0.001 – 2.125 $ 0.88 Warrants Expired/Forfeited (48,106 ) $ 3.118 $ 3.118 Balance at December 31, 2022 10,387,877 $ 1.35 – 9.00 5.11 Years $ 1.56 $ - Share-Based Compensation On October 24, 2019, the Company’s 2019 Equity Incentive Plan (the “Plan”) RSUs”) The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. Stock Options As of December 31, 2023 and December 31, 2022, the Company has granted stock options to acquire 1,692,473 and 1,086,813 shares of common stock under the Plan, respectively. As of December 31, 2023, the Plan had 1,014,828 vested options and 677,645 non-vested options. As of December 31, 2022, the Plan had 930,573 vested options and 173,009 non-vested options. The stock options are held by our officers, directors, employees, and certain key consultants. For the years ended December 31, 2023 and 2022, the Company recorded in stock-based compensation expense $1,604,827 and $1,582,217, respectively, of share-based compensation related to stock options. The unrecognized compensation expense as of December 31, 2023 was $1,138,937 which will be recognized over periods ranging from 5 to 34 months. On November 4, 2022, the Company’s Board of Directors approved for a total of 305,000 stock options having exercise prices ranging from $8.25 - $10.56 to be repriced at 110% ($2.39) and 100% ($2.17) of the current price of the Company’s stock for employees and Board members, respectively. The incremental fair value of the options as a result of the repricing was determined to be $55,859. Of this amount, $29,900 related to vested options and was recognized as compensation expense in 2022. The remaining $1,786 of unrecognized expense will be recognized over periods ranging from 3 to 9 months. In applying the Black-Scholes options pricing model, assumptions used to compute the fair value of the stock options granted or repriced during the years ended December 31, 2023 and 2022 were as follows: December 31, 2023 December 31, 2022 Exercise Price $ 0.48-2.16 $ 1.54-9.075 Dividend Yield 0 % 0 % Volatility 143%-207% 89%-192% Risk-free Interest Rate 4.09%-5.04% 0.78%-4.01% Expected Life 1-6 years 1-3 years The following tables summarize the changes in the Company’s outstanding stock options during the years ended December 31, 2023 and 2022: Options Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2021 1,053,356 $ 0.79 - 10.74 6.21 Years $ 3.40 $ 5,804,517 Options Granted 120,000 $ 1.54 - 9.08 3.42 Years $ 5.79 $ - Options Exercised (48,106 ) $ 0.79 $ 0.79 Options Cancelled - Options Expired/Forfeited (21,667 ) $ 4.94 - 10.73 $ 9.33 Balance at December 31, 2022 1,103,583 $ 0.79 - 9.30 5.33 Years $ 1.71 $ - Exercisable at December 31, 2022 930,573 $ 0.79 - 9.30 5.83 Years $ 1.60 $ - Options Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2022 1,103,583 $ 0.79 - 9.30 5.33 Years $ 1.71 $ - Options Granted 1,075,000 $ 0.48-2.32 4.09 Years $ 1.17 - Options Exercised - Options Cancelled - Options Expired/Forfeited (486,110 ) $ 0.79-2.39 - $ 1.19 $ - Balance at December 31, 2023 1,692,473 0.48-9.30 5.66 $ 2.01 $ - Exercisable at December 31, 2023 1,014,828 0.48-9.30 4.36 $ 2.14 $ - Restricted Stock Units The Plan provides for the grant of RSUs. RSUs are settled in shares of the Company’s common stock as the RSUs become vested. During the year ended December 31, 2023, the Company granted 148,080 service based RSUs to executive officers and employees and no service based RSUs to directors. All RSUs granted in 2023 vest during various periods between November 2023 and January 2026. During the year ended December 31, 2022, the Company granted 281,667 service based RSUs to executive officers and employees and 140,000 service based RSUs to directors. All RSUs granted in 2023 vest during various periods between November 2023 and January 2026. The following table summarizes RSU activity under the Plan for the years ended December 31, 2023 and 2022: RSUs Weighted Average Grant Date Fair Value Per Share Weighted Average Vesting Period Unvested at December 31, 2022 380,000 $ 2.17 0.74 Years Granted 148,080 1.18 1.60 Years Vested (315,000 ) $ 1.90 Unvested at December 31, 2023 213,080 $ 1.88 1.74 Years For the years ended December 31, 2023 and 2022, the Company recorded in stock-based compensation expense $641,043 and $1,426,178, respectively, of RSU based compensation. The fair value of RSUs granted during the years ended December 31, 2023, and 2022 was $174,062 and $1,112,725, respectively. As of December 31, 2023, total unrecognized compensation costs of RSUs granted and outstanding but not yet vested was $124,190 which is expected to be recognized over 24 months. Executive Officers Stock Options and RSUs The Company had 437,372 outstanding executive officers stock options exercisable at $0.7902 to $2.387 per share with a weighted average remaining contractual life of 7.51 years as of December 31, 2023, and 537,371 outstanding executive stock options exercisable at $0.7902 to $2.387 per share with a weighted average remaining contractual life of 5 years as of December 31, 2022. The Company had 98,080 unvested RSUs granted to executive officers with a remaining weighted average vesting period of 24 months as of December 31, 2023. The Company had 200,000 unvested RSUs granted to executive officers with a remaining weighted average vesting period of 5 months as of December 31, 2022. On January 1, 2022, the Company entered into an Employment Agreement with Jerry Wenzel to serve as the Company’s Chief Financial Officer for a two-year period. Under the terms of the agreement, the Company granted Mr. Wenzel under the Plan stock options to acquire 66,667 shares of our common stock at an exercise price of $8.25 per share, repriced effective November 4, 2022 to an exercise price of $2.387 per share, and 16,667 RSUs. The stock options vest in equal quarterly installments over a two-year period during the term of his Employment Agreement. On November 4, 2022, Mr. Wenzel was granted 75,000 RSUs that vest June 1, 2023. The RSUs per share weighted average fair value at grant date was $2.17. On November 10, 2023, Mr. Wenzel was granted 50,000 RSUs that vested immediately. The RSUs per share weighted average fair value at grant date was $0.48. Mr. Wenzel was granted a total of 66,667 stock options that were vested as of December 31, 2023. None of the vested stock options have been exercised and no shares have been issued as of December 31, 2023. A total of 125,000 RSUs vested in 2023 and common shares were issued in the same amount. On January 30, 2023, the Company entered into an Employment Agreement with David Gandini to continue to serve as the Company’s Chief Executive Officer through December 31, 2025. On February 23, 2023, Mr. Gandini was granted stock options to acquire 510,000 shares of our common stock at an exercise price of $2.32 per share. The options vest in equal quarterly installments over a period of 34 months. Mr. Gandini was granted a total of 50,000 stock options that were vested as of December 31, 2023. None of the vested stock options have been exercised and no shares have been issued as of December 31, 2023. On August 4, 2023, Mr. Gandini was granted 98,080 RSUs that vest January 1, 2026. The RSUs per share weighted average fair value at grant date was $1.53. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended |
Dec. 31, 2023 | |
COMMITMENTS AND CONTINGENCIES | |
COMMITMENTS AND CONTINGENCIES | NOTE 13. COMMITMENTS AND CONTINGENCIES Legal Proceedings On December 6, 2006, Orange County Valet and Security Patrol, Inc. filed a lawsuit against us in Orange County California State Superior Court for Breach of Contract in the amount of $11,164. A default judgment was taken against us in this matter. In mid-2013, we learned the Plaintiff’s perfected the judgment against us, but we have not heard from the Plaintiffs as of December 2023. As of December 31, 2023, the Company has accrued $11,164 plus accrued interest of approximately $19,000. In the event we pay any money related to this lawsuit, IDTEC agreed, in connection with us closing a 2020 asset purchase transaction with IDTEC, to pay the amount for us in exchange for shares of our common stock. |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Dec. 31, 2023 | |
INCOME TAXES | |
INCOME TAXES | NOTE 14. INCOME TAXES Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses. These loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur. For the years ended December 31, 2023, and 2022, the Company incurred net losses and therefore has no tax liability. The Company began operations in 2007 and has net operating loss carry-forwards of approximately $39,824,000 that will be carried forward and can be used through the year 2028 and beyond to offset future taxable income. In the future, the cumulative net operating loss carry forward for income tax purposes may differ from the cumulative financial statement loss due to timing differences between financial and tax reporting. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards of approximately $39,824,000 for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be further limited to use in future years. As of December 31, 2023 and 2022, the deferred tax asset of approximately $9,714,000 and $7,283,000, respectively, created by the net operating losses has been offset by a 100% valuation allowance because the likelihood of realization of the tax benefit cannot be determined. The change in the valuation allowance in 2023 and 2022 was approximately $2,429,000 and $3,154,000, respectively. There is no current or deferred tax expense for the years ended December 31, 2023 and 2022. The Company has not filed its tax returns for the years 2012 through 2023; however, management believes there are no taxes due as of December 31, 2023 and 2022. The Company includes interest and penalties arising from the underpayment of income taxes in general and administrative expense in the consolidated statements of operations. The provision for Federal income tax consisted of the following for the years ended December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Income tax benefit attributable to: Net loss $ (10,214,704 ) $ (12,354,930 ) Permanent differences 2,382,227 1,732,832 Valuation allowance 7,832,477 10,622,098 Net provision for income tax $ - $ - The cumulative tax effect at the expected federal tax rate of 21% of significant items comprising our net deferred tax amount is as follows on December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Deferred tax asset attributable to: Net operating loss carry forward $ 7,723,005 $ 5,759,000 Valuation allowance (7,723,005 ) (5,759,000 ) Net deferred tax asset $ - $ - The cumulative tax effect at the expected state tax rate of 5% of significant items comprising our net deferred tax amount is as follows on December 31, 2023 and 2022: December 31, 2023 December 31, 2022 Deferred tax asset attributable to: Net operating loss carry forward $ 1,991,222 $ 1,524,000 Valuation allowance (1,991,222 ) (1,524,000 ) Net deferred tax asset $ - $ - The Company has identified the United States Federal tax returns as its “major” tax jurisdiction. The United States Federal tax return years 2012 – 2023 are still subject to tax examination by the United States Internal Revenue Service; however, we do not currently have any ongoing tax examinations. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2023 | |
SUBSEQUENT EVENTS | |
SUBSEQUENT EVENTS | NOTE 15. SUBSEQUENT EVENTS The Company has evaluated subsequent events for recognition and disclosure through March 29, 2024, which is the date the consolidated financial statements were available to be issued. On March 5, 2024, the Company’s Senior Convertible Noteholders elected to convert a total of $804,695 (the “Conversion Amount”) pertaining to the 2023 Debt Offering into 1,297,895 shares of the Company’s common stock at $0.62 per share. The issuance of these securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933. The investors are sophisticated, familiar with our operations, and there was no general solicitation or advertising. In addition, pursuant to the March 4, 2024, Inducement Letters, the exercise prices for Common Stock Purchase Warrants issued on September 30, 2022, in relation to the PIPE Offering and Common Stock Purchase Warrants issued on March 9, 2023 related to the 2023 Debt Offering were permanently reduced to $0.62 per share. On March 6, 2024, pursuant to the Adjustment terms of the March 2022 Armistice Warrants and the September 2021 Armistice Warrant as a result of the Inducement Letters, the Company issued an aggregate 2,659,031 warrants (the “Armistice Warrants”) consisting of (i) 2,127,225 warrants pursuant to the Adjustment terms under the September 2021 Armistice Warrant, and (ii) 531,806 warrants pursuant to the Adjustment terms of the March 2022 Armistice Warrant. In addition, the Armistice Warrants include conditions where the warrant exercise price may be adjusted downward in the event securities instruments or exercise prices are subsequently issued or reduced, respectively, below the then current exercise prices of $1.35 per unit of the Armistice Warrants. Where the Inducement Letters stipulate a reduction in the warrant securities exercise prices below the Armistice Warrant exercise price of $1.35 per unit, the conditions of a downward adjustment were met reducing the Armistice Warrants exercise price permanently to $0.62 per unit. The issuance of these securities was exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933. The investor is accredited, familiar with our operations, and there was no general solicitation or advertising. |
ORGANIZATION OPERATIONS AND S_2
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Basis of Presentation | The accompanying audited consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for the presentation of annual financial information. In management’s opinion, the audited consolidated financial statements reflect all adjustments (including reclassifications and normal recurring adjustments) necessary to present fairly the financial position at December 31, 2023 and December 31, 2022, and results of operations and cash flows for the years ended December 31, 2023 and December 31, 2022. |
Principles of Consolidation | The accompanying audited consolidated financial statements include the accounts of the Company and its majority-owned subsidiary, TransBiotec-CA, of 98.6%. We have eliminated all intercompany transactions and balances between entities consolidated in these audited financial statements. |
Use of Estimates | The preparation of audited consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the recoverability and useful lives of long-lived assets, the intellectual technology, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results could differ from those estimates. |
Financial Instruments | The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The fair value hierarchy is based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company prioritizes the inputs into three levels that may be used to measure fair value: Level Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets: quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist primarily of cash, accounts receivable, accounts payable, accrued expenses, accrued interest payable, related party payables, notes payable, and other liabilities. The Company believes that the recorded values of our financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. At December 31, 2023 and December 31, 2022, the Company did not have financial instruments requiring valuation from observable or unobservable inputs to determine fair value on a recurring basis. |
Cash | The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of December 31, 2023 and December 31, 2022. |
Accounts Receivable | Customer accounts are monitored for potential credit losses based upon management’s assessment of expected collectability and the allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration any circumstances of which the Company is aware regarding a customer’s inability to meet its financial obligations to the Company, and any potential prevailing economic conditions and their impact on the Company’s customers. The Company had $982 in allowance for doubtful accounts and no allowance for doubtful accounts at December 31, 2023 and December 31, 2022, respectively. |
Inventory | Inventory is comprised of component parts and finished product and is valued at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. The Company evaluates the valuation of inventory and periodically adjusts the value for estimated excess based upon estimates of future demand and market conditions, and obsolete inventory based upon otherwise damaged or impaired goods. The Company had no reserves for obsolescence at December 31, 2023 and December 31, 2022. |
Prepaid Expenses | Amounts incurred in advance of contractual performance or coverage periods are recorded as prepaid assets and recognized as expense in the period service or coverage is provided. |
Beneficial Conversion Features | As discussed under “Recently Adopted Accounting Standard” in Note 1, the Company adopted ASU 2020-06 effective January 1, 2023, which, among other things, eliminated the beneficial conversion feature model applicable to certain convertible instruments. Prior to the adoption of ASU 2020-06, a beneficial conversion feature existed on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature was recorded as a debt discount with a corresponding amount to additional paid-in capital. The debt discount was amortized to interest expense over the life of the note using the effective interest method. |
Derivative Instruments | The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The classification of derivate instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. For derivative financial instruments that are accounted for as liabilities, the derivative instruments are initially recorded at their fair values and are then re-valued at each reporting date, with changes in the fair value reported in the audited consolidated statements of operations under other income (expense). The company had no derivative instruments as of December 31, 2023. |
Debt Issuance Costs | Debt issuance costs incurred in connection with the issuance of debt are capitalized and amortized to interest expense over the term of the debt using the effective interest method. The unamortized amount is presented as a reduction of debt on the audited consolidated balance sheet. |
Preferred Stock | Preferred shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred shares (if any), which includes preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control, as temporary equity. At all other times, the Company classifies preferred shares in stockholders’ equity. |
Noncontrolling Interest | A subsidiary of the Company has minority members representing ownership interests of 1.4% at December 31, 2023 and December 31, 2022. The Company accounts for this noncontrolling interest whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance. |
Impairment of Long-Lived Assets | Long-lived assets and identifiable intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. If the sum of undiscounted expected future cash flows is less than the carrying amount of the asset or if changes in facts and circumstances indicate, an impairment loss is recognized and measured using the asset’s fair value. No impairment loss was recognized during the years ended December 31, 2023 and 2022, respectively. |
Revenue Recognition | The Company enters contracts with customers and generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services. Depending on the combination of products and services detailed in the respective customer contract, the identifiable components may be highly interdependent and interrelated with each other such that each is required to provide the substance of the value of the Company’s offering and accounted for as a combined performance obligation, or the specific components may be generally distinct and accounted for as separate performance obligations. Revenue is recognized when control of these software products and/or services are transferred to the customer in an amount that reflects the consideration the Company expects to be entitled in exchange for these respective services and devices. The Company determines revenue recognition through five steps which include (1) the identification of the contract or contracts with a customer, (2) identification of individual or combined performance obligations contained in the contract, (3) determination of the transaction price detailed within the contract, (4) allocation of the transaction price to the specific performance obligations, and (5) finally, recognition of revenue as the Company’s performance obligations are satisfied according to the terms of the contract. Contracts with a Single License/Service Performance Obligation For contracts with a single performance obligation consisting of a license and/or data services, the entire transaction price is allocated to the single performance obligation. Where the Company provides a performance obligation as licensed software or data services, revenue is recognized upon delivery of the software or services ratably over the respective term of the contract. Contracts for Purchase of Hardware Devices Only Where hardware devices are sold separately by the Company, the entire transaction price is allocated to the device as an individual performance obligation and revenue is recognized at a point in time when either legal title, physical possession or the risks and rewards of ownership have transferred to the customer. Generally, these requirements are satisfied at the point in time the Company ships the product, as this is when the customer obtains control of the asset under the Company’s standard terms and conditions of the purchase. Contracts with Multiple Performance Obligations Where a Company’s contract with a respective customer contains multiple performance obligations and due to the interdependent and interrelated nature of the licensed software, hardware devices and data reporting services, the Company accounts for the individual performance obligations if they are distinct in nature and the transaction price is allocated to each distinct performance obligations on a directly observable standalone sales price basis. Determining whether products and services are distinct performance obligations that should be accounted for separately or combined as one unit of accounting may require significant judgment. Standalone selling prices are primarily based upon the price at which the performance obligation is sold separately. The Company may be able to establish a standalone sales price based upon observable products or services sold or priced separately in comparable circumstances, competitor pricing or similar customers. Where the performance obligations are either not distinct or directly observable, the Company estimates the standalone sales price of the performance obligations based upon the overall pricing objectives taking into consideration the value of the contract arrangement, number of licenses, number and types of hardware devices and the length of term of the contract. Professional judgement may be required to determine the standalone sales price for each performance obligation where not directly observable. Revenue for Contracts with Multiple Performance Obligations is recognized on a ratable basis for each respective performance obligation as allocated under the prescribed transaction price identification model applied. The Company requires customers to make payments related to subscribed software licenses and data services on a monthly basis via authorized bank account ACH withdrawal or an automatic credit card charge during the approved term of the respective agreement. The collectability of future cash flows are reasonably assured with any potential non-payment easily identified with future services being discontinued or suspended due to non-payment. The Company’s contracts are generally twelve to thirty-six months in duration, are billed monthly in advance and are non-cancelable. The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced and a receivable is recorded. A contract asset (unbilled revenue) is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company has elected to charge shipping, freight and delivery to customers as a source of revenue to offset respective costs when control has transferred to the customer. The Company reports revenue net of sales and other taxes collected from customers to be remitted to government authorities. Estimated costs for the Company’s standard one-year warranty are charged to cost of goods and services when revenue is recorded for the related product. Royalties are also charged to cost of goods and services. |
Leases | The Company determines if an arrangement is or contains a lease at inception. Leases with an initial term of twelve months or less are considered short-term leases and are not recognized on the Company’s audited consolidated balance sheet. Right-of-use (“ROU”) assets and liabilities are recognized on the audited consolidated balance sheet for leases with an expected term greater than twelve months. Operating lease ROU assets represent our right to use an underlying asset over the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at inception based on the present value of lease payments over the lease term. When the rate implicit in the lease is not determinable, the Company uses its estimated secured incremental borrowing rate in determining the present value of lease payments. The lease expense for fixed lease payments is recorded on a straight-line basis over the lease term and variable lease payments are included in the lease expense when the obligation for those payments is incurred. The Company has elected not to separate lease and non-lease components. |
Stock-based Compensation | The Company uses the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (warrants, options, and restricted stock units). The fair value of each warrant and option is estimated on the date of grant using the Black-Scholes options pricing model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. The Company has not paid dividends historically and does not expect to pay them in the future. Expected volatilities are based on weighted averages of the historical volatility of the Company’s common stock estimated over the expected term of the awards. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term. The grant date fair value of a restricted stock unit equals the closing price of our common stock on the trading day of the grant date. |
Research and Development | Research and development costs are expensed as incurred. The Company incurred research and development costs as it acquired new knowledge to bring about significant improvements in the functionality and design of its products. |
Advertising and Marketing Costs | Advertising and marketing costs are charged to operations as incurred. Advertising and marketing costs were $190,614 and $169,010 during the years ended December 31, 2023 and December 31, 2022, respectively. |
Income Tax | Deferred taxes are provided on an asset and liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company has not recorded any deferred tax assets or liabilities at December 31, 2023 and December 31, 2022 as these have been offset by a 100% valuation allowance. |
Loss Per Share | Basic loss per common share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted loss per share gives the effect to all dilutive potential common shares outstanding during the period, including stock options, warrants and convertible instruments. Diluted net loss per share excludes all potentially issuable shares if their effect is anti-dilutive. Because the effect of the Company’s dilutive securities is anti-dilutive, diluted net loss per share is the same as basic loss per share for the periods presented. |
Concentration of Risk | Credit Risk – Concentration of Customers Concentration of Suppliers |
Related Parties | Related parties are any entities or individuals that, through employment, ownership or other means, possess the ability to direct or cause the direction of the management and policies of the Company. |
Recently Adopted Accounting Standards | In August 2020, the FASB issued ASU 2020-06, Debt– Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity The Company early adopted ASU 2020-06 effective January 1, 2023, using the modified retrospective method whereby the cumulative effect of the change is recognized as an adjustment to the opening balance of retained earnings at the date of adoption. On January 1, 2023, the Company recorded an increase to retained earnings (accumulated deficit) of $776,569 and a decrease to additional paid-in capital of $909,214 to fully remove the unamortized debt discount related to beneficial conversion features of $132,646. The Company has reviewed other recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations. |
Reclassifications | Certain prior period amounts have been reclassified to conform with the current period presentation. None of these reclassifications had a material impact on the audited consolidated financial statements. |
INVENTORY (Tables)
INVENTORY (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
INVENTORY | |
Schedule of inventory | December 31, December 31, 2023 2022 Component parts $ 59,157 $ 68,643 Finished goods 283,625 146,850 Inventory $ 342,782 $ 215,493 |
PREPAID EXPENSES (Tables)
PREPAID EXPENSES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
PREPAID EXPENSES | |
Schedule of prepaid expenses | December 31, December 31, 2023 2022 Insurance $ 156,724 $ 150,344 Deposit 15,736 15,736 Rent 16,714 - Other 24,087 34,825 Prepaid expenses $ 213,261 $ 200,905 |
LEASES (Tables)
LEASES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
LEASES | |
Schedule of operating lease obligations | Operating lease liabilities, current portion $ 97,108 Operating lease liabilities – less current portion 203,295 Total Operating Lease Liabilities $ 300,403 |
Schedule of future lease payments | 2024 $ 121,831 2025 125,644 2026 95,063 Total future minimum lease payments 342,538 Less imputed interest (42,135 ) Total Operating Lease Liabilities $ 300,403 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
INTANGIBLE ASSETS | |
Summary of Intangible Assets | Gross Carrying Accumulated Net Intangible Amortization Period Amount Amortization Asset (in years) SOBRsafe TM $ 3,854,675 $ 1,381,246 $ 2,473,429 10 Gross Carrying Accumulated Net Intangible Amortization Period Amount Amortization Asset (in years) SOBRsafe TM $ 3,854,675 $ 995,782 $ 2,858,893 10 |
Schedule of estimated future amortization expense | 2024 2025 2026 2027 2028 Thereafter $ 385,464 $ 385,464 $ 385,464 $ 385,464 $ 385,464 $ 546,109 |
ACCRUED EXPENSES (Tables)
ACCRUED EXPENSES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
ACCRUED EXPENSES | |
Schedule of Accrued expenses | December 31, 2023 December 31, 2022 Consulting services 328,196 197,897 R&D services 220,000 - Other 178,744 194,385 Accrued expenses $ 726,940 $ 392,282 |
NOTES PAYABLE (Tables)
NOTES PAYABLE (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
NOTES PAYABLE | |
Schedule of notes payables - related parties | December 31, 2023 December 31, 2022 Convertible Notes Payable with Warrants – 2021 Debt Offering $ - $ 1,000,000 Non-Convertible Notes Payable 11,810 11,810 Unamortized Debt Discount - (145,548 ) Net Related Party Notes Payable $ 11,810 $ 866,262 Current Portion (11,810 ) (866,262 ) Net Long-Term Portion $ - $ - |
Schedule of notes payables - non related parties | December 31, 2023 December 31, 2022 Convertible Notes Payable with Warrants – 2023 Debt Offering $ 3,219,724 $ - Convertible Notes Payable with Warrants – 2021 Debt Offering - 1,005,000 Convertible Notes Payable 9,183 9,183 Non-Convertible Notes Payable 17,500 17,500 Premium Financing Note Payable 37,648 61,792 Unamortized Debt Discount (913,826 ) (144,878 ) Net Non-Related Party Notes Payable $ 2,370,229 $ 948,597 Current Portion (64,331 ) (948,597 ) Net Long-Term Portion $ 2,305,898 $ - |
STOCK WARRANTS STOCK OPTIONS _2
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS | |
Schedule of fair value of warrant and stock options granted | December 31, 2023 December 31, 2022 Exercise Price $ 1.35-2.52 $ 1.35-6.00 Dividend Yield 0 % 0 % Volatility 162-209% 110-160% Risk-free Interest Rate 4.56-4.73% 2.45–4.62% Life of Warrants 3-5 Years 1-7 Years |
Schedule of warrant And Option outstanding Stock | Warrants Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2022 10,387,877 $ 1.35 -9.00 5.11 Years $ 1.56 $ - Warrants Granted 611,998 1.35-2.52 3.39 Years 2.09 - Warrants Exercised - Warrants Expired 394,167 2.56-9.00 0 Years 8.02 - Balance at December 31, 2023 10,605,708 1.35-5.31 4.59 Years 1.70 - Warrants Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2021 836,464 $ 1.50 – 9.00 3.04 Years $ 6.78 $ 1,784,838 Warrants Granted 13,375,461 $ 1.35 – 5.3125 4.38 Years $ 1.94 $ - Warrants Exercised (3,775,942 ) $ 0.001 – 2.125 $ 0.88 Warrants Expired/Forfeited (48,106 ) $ 3.118 $ 3.118 Balance at December 31, 2022 10,387,877 $ 1.35 – 9.00 5.11 Years $ 1.56 $ - |
Schedule of options pricing model | December 31, 2023 December 31, 2022 Exercise Price $ 0.48-2.16 $ 1.54-9.075 Dividend Yield 0 % 0 % Volatility 143%-207% 89%-192% Risk-free Interest Rate 4.09%-5.04% 0.78%-4.01% Expected Life 1-6 years 1-3 years |
Schedule of outstanding stock options | Options Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2021 1,053,356 $ 0.79 - 10.74 6.21 Years $ 3.40 $ 5,804,517 Options Granted 120,000 $ 1.54 - 9.08 3.42 Years $ 5.79 $ - Options Exercised (48,106 ) $ 0.79 $ 0.79 Options Cancelled - Options Expired/Forfeited (21,667 ) $ 4.94 - 10.73 $ 9.33 Balance at December 31, 2022 1,103,583 $ 0.79 - 9.30 5.33 Years $ 1.71 $ - Exercisable at December 31, 2022 930,573 $ 0.79 - 9.30 5.83 Years $ 1.60 $ - Options Outstanding Number of Shares Exercise Price Per Share Weighted Average Remaining Contractual Life Weighted Average Exercise Price Per Share Aggregate Intrinsic Value Balance at December 31, 2022 1,103,583 $ 0.79 - 9.30 5.33 Years $ 1.71 $ - Options Granted 1,075,000 $ 0.48-2.32 4.09 Years $ 1.17 - Options Exercised - Options Cancelled - Options Expired/Forfeited (486,110 ) $ 0.79-2.39 - $ 1.19 $ - Balance at December 31, 2023 1,692,473 0.48-9.30 5.66 $ 2.01 $ - Exercisable at December 31, 2023 1,014,828 0.48-9.30 4.36 $ 2.14 $ - |
Schedule of RSU activity under the Plan | RSUs Weighted Average Grant Date Fair Value Per Share Weighted Average Vesting Period Unvested at December 31, 2022 380,000 $ 2.17 0.74 Years Granted 148,080 1.18 1.60 Years Vested (315,000 ) $ 1.90 Unvested at December 31, 2023 213,080 $ 1.88 1.74 Years |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
INCOME TAXES | |
Schedule of components of income tax benefit | December 31, 2023 December 31, 2022 Income tax benefit attributable to: Net loss $ (10,214,704 ) $ (12,354,930 ) Permanent differences 2,382,227 1,732,832 Valuation allowance 7,832,477 10,622,098 Net provision for income tax $ - $ - |
Schedule of deferred tax assets | December 31, 2023 December 31, 2022 Deferred tax asset attributable to: Net operating loss carry forward $ 7,723,005 $ 5,759,000 Valuation allowance (7,723,005 ) (5,759,000 ) Net deferred tax asset $ - $ - |
Schedule of cumulative tax effect 5% | December 31, 2023 December 31, 2022 Deferred tax asset attributable to: Net operating loss carry forward $ 1,991,222 $ 1,524,000 Valuation allowance (1,991,222 ) (1,524,000 ) Net deferred tax asset $ - $ - |
ORGANIZATION OPERATIONS AND S_3
ORGANIZATION OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Jan. 01, 2023 | |
Advertising and marketing costs | $ 190,614 | $ 169,010 | |
FDIC insured amount | $ 250,000 | ||
Valuation allowance, percentage | 100% | 100% | |
Retained Earning (Accumulated Deficit) | $ (87,765,981) | $ (78,327,845) | $ 776,569 |
Allowance for doubtful accounts | $ 982 | $ 0 | |
Additional paid in capital | 909,214 | ||
Unamortized debt discount related to beneficial conversion features | $ 132,646 | ||
Minority Interest [Member] | |||
Ownership interest, percentage | 1.40% | 1.40% |
GOING CONCERN (Details Narrativ
GOING CONCERN (Details Narrative) | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
GOING CONCERN | |
Accumulated deficit | $ (87,800,000) |
Convertible notes payable | 2,305,000 |
Net cash used in operating activities | 5,900,000 |
Working capital | (1,900,000) |
Cash balances | $ 2,800,000 |
INVENTORY (Details)
INVENTORY (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
INVENTORY | ||
Components parts | $ 59,157 | $ 68,643 |
Finished goods | 283,625 | 146,850 |
Inventory, net | $ 342,782 | $ 215,493 |
PREPAID EXPENSES (Details)
PREPAID EXPENSES (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
PREPAID EXPENSES | ||
Insurance | $ 156,724 | $ 150,344 |
Deposits | 15,736 | 15,736 |
Rent | 16,714 | 0 |
Other | 24,087 | 34,825 |
Prepaid expenses | $ 213,261 | $ 200,905 |
PREPAID EXPENSES (Details Narra
PREPAID EXPENSES (Details Narrative) - USD ($) | Dec. 31, 2023 | May 18, 2023 | Dec. 31, 2022 | May 25, 2022 |
Insurance | $ 156,724 | $ 150,344 | ||
Annual premiums | $ 367,352 | $ 349,455 | ||
Directors & Officers | ||||
Insurance | $ 9,167 |
LEASES (Details)
LEASES (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
LEASES | ||
Operating lease liabilities, current portion | $ 97,108 | $ 0 |
Operating lease liabilities - less current portion | 203,295 | $ 0 |
Total Operating Lease Liabilities | $ 300,403 |
LEASES (Details 1)
LEASES (Details 1) | Dec. 31, 2023 USD ($) |
LEASES | |
2024 | $ 121,831 |
2025 | 125,644 |
2026 | 95,063 |
Total future minimum lease payments | 342,538 |
Less imputed interest | (42,135) |
Total Operating Lease Liabilities | $ 300,403 |
LEASES (Details Narrative)
LEASES (Details Narrative) | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Monthly lease payments | $ 329 |
Total operating lease expense | 180,895 |
Variable lease expenses | 38,719 |
Short-term lease expense | $ 65,375 |
Weighted average remaining lease term | 33 months |
Weighted average discount rate | 10% |
office facility lease agreement [Member] | |
Monthly rent | $ 9,744 |
Description of new office facility agreement | twelve-month period beginning July 1, 2022 |
Desription of extend the term of the lease | from July 1, 2023 through September 30, 2026. The amended lease provides for monthly base rent of $9,310 through September 2024, with fixed escalating monthly base rent for each year thereafter |
INTANGIBLE ASSETS (Details)
INTANGIBLE ASSETS (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Intangible assets, net | $ 2,473,429 | $ 2,858,893 |
Intellectual Technology [Member] | ||
Amortization Period | 10 years | 10 years |
Gross carrying amount | $ 3,854,675 | $ 3,854,675 |
Accumulated amortization | (1,381,246) | (995,782) |
Intangible assets, net | $ 2,473,429 | $ 2,858,893 |
INTANGIBLE ASSETS (Details 1)
INTANGIBLE ASSETS (Details 1) | Sep. 30, 2023 USD ($) |
INTANGIBLE ASSETS | |
2024 | $ 385,464 |
2025 | 385,464 |
2026 | 385,464 |
2027 | 385,464 |
2028 | 385,464 |
Thereafter | $ 546,109 |
INTANGIBLE ASSETS (Details Narr
INTANGIBLE ASSETS (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
INTANGIBLE ASSETS | ||
Amortization expense | $ 385,464 | $ 385,464 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - Board of Directors [Member] - Series B Convertible Preferred Stock [Member] - shares | Apr. 20, 2023 | Mar. 01, 2022 |
Common stock, shares held | 666,667 | |
Designation shares of Preferred Stock | 3,000,000 | 3,000,000 |
Preferred Stock shares issued in exchange for common stock | 1,000,000 | 333,333 |
ACCRUED EXPENSES (Details)
ACCRUED EXPENSES (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
ACCRUED EXPENSES | ||
Consulting services | $ 328,196 | $ 197,897 |
R&D services | 220,000 | 0 |
Other | 178,744 | 194,385 |
Accrued expenses | $ 726,940 | $ 392,282 |
NOTES PAYABLE (Details)
NOTES PAYABLE (Details) - Related Party Notes Payable [Member] - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Convertible Notes Payable with Warrants - 2021 Debt Offering | $ 0 | $ 1,000,000 |
Non-Convertible Notes Payable | 11,810 | 11,810 |
Unamortized Debt Discount | 0 | (145,548) |
Net Related Party Notes Payable | 11,810 | 866,262 |
Current portion | (11,810) | (866,262) |
Net Long-Term Portion | $ 0 | $ 0 |
NOTES PAYABLE (Details 1)
NOTES PAYABLE (Details 1) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Convertible Notes Payable | $ 2,305,000 | |
Non-Related Party Notes Payable [Member] | ||
Convertible Notes Payable with Warrants - 2023 Debt Offering | 3,219,724 | $ 0 |
Convertible Notes Payable with Warrants - 2021 Debt Offering | 0 | 1,005,000 |
Convertible Notes Payable | 9,183 | 9,183 |
Non-Convertible Notes Payable | 17,500 | 17,500 |
Premium Financing Note Payable | 37,648 | 61,792 |
Unamortized Debt Discount | (913,826) | (144,878) |
Net Related Party Notes Payable | 2,370,229 | 948,597 |
Current portion | (64,331) | (948,597) |
Net Long-Term Portion | $ 2,305,898 | $ 0 |
NOTES PAYABLE (Details Narrativ
NOTES PAYABLE (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | ||||
May 10, 2023 | Jun. 15, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | May 18, 2023 | May 25, 2022 | |
Insurance premiums | $ 367,352 | $ 349,455 | ||||
Financing liability | $ 37,648 | |||||
Initial down payment | $ 74,866 | |||||
Remaining amount | $ 293,882 | |||||
Annual interest rate | 4.37% | |||||
Monthly payments | 37,914 | $ 31,068 | ||||
Interest expense related party | $ 120,000 | |||||
Amortization of debt discount | 562,690 | 2,295,586 | ||||
Loss on debt extinguishment | (26,125) | 245,105 | ||||
Accrued interest | 96,988 | 469,691 | ||||
Proceed from debt | 0 | 3,048,781 | ||||
Proceeds from notes payable - non-related parties | 3,000,001 | 0 | ||||
Non-Convertible Notes Payable [Member] | ||||||
Convertible notes payable principal | 17,500 | |||||
Convertible Notes Payable Two [Member] | ||||||
Convertible notes payable, principal amount | $ 9,183 | |||||
Interest rate | 12% | |||||
Common stock price pe share | $ 32.29 | |||||
Minimum [Member] | Non-Convertible Notes Payable [Member] | ||||||
Note payable due date | December 2013 | |||||
Interest rate | 9% | |||||
Maximum [Member] | Non-Convertible Notes Payable [Member] | ||||||
Note payable due date | November 2015 | |||||
Interest rate | 10% | |||||
2023 Debt [Member] | ||||||
Total conversion amount | $ 341,999 | |||||
Debt Offering into shares of common stock | 150,000 | |||||
Conversion note principal, amount | $ 309,688 | |||||
Number of warrants to purchase common stock | 386,998 | |||||
Convertible into the common stock at per share | $ 2.28 | |||||
Accrued interest | $ 32,311 | |||||
Convertible notes payable, principal amount | $ 3,529,412 | |||||
Related Party Notes Payable [Member] | ||||||
Convertible notes payable principal | $ 11,810 | 866,262 | ||||
Related Party Notes Payable [Member] | Convertible Notes Payable with Warrants - 2021 Debt Offering | ||||||
Interest rate | 12% | |||||
Interest expense for non related party | $ 62,837 | 275,500 | ||||
Unamortized debt discount | 551,001 | 66,843 | ||||
Amortization of interest beneficial conversion feature | $ 167,913 | 167,913 | ||||
Purchase price of shares issued | $ 9 | |||||
Principle balance | $ 1,000,000 | |||||
Total beneficial conversion feature debt discount | $ 448,999 | |||||
Convertible into the common stock at per share | $ 9 | |||||
Loss on debt extinguishment | $ 26,125 | |||||
Non-Related Party Notes Payable [Member] | ||||||
Convertible notes payable principal | $ 64,331 | 948,597 | ||||
Non-Related Party Notes Payable [Member] | Convertible Notes Payable with Warrants - 2021 Debt Offering | ||||||
Interest rate | 12% | |||||
Interest expense for non related party | $ 240,311 | 134,628 | ||||
Unamortized debt discount | 541,707 | 65,803 | ||||
Amortization of debt discount | 68,818 | 272,350 | ||||
Amortization of interest beneficial conversion feature | 0 | $ 231,353 | ||||
Principle balance | $ 1,005,000 | |||||
Issue price | $ 9 | |||||
Total beneficial conversion feature debt discount | $ 460,215 | |||||
Convertible into the common stock at per share | $ 9 | |||||
Loss on debt extinguishment | $ 10,257 | |||||
Related Party Non Convertible Notes Payable [Member] | ||||||
Interest rate | 0% | |||||
Non-Related Party [Member] | Notes Payable [Member] | ||||||
Convertible notes payable, principal amount | 367,352 | |||||
Original Issue Discount of conertible notes | 15% | |||||
Common stock conversion price | $ 2.28 | |||||
Notes due date | March 10, 2025 | |||||
Accrued interest, per annum | 5% | |||||
Excercise price | $ 2.52 | |||||
Down payment | $ 73,470 | |||||
Proceed from debt | $ 2,500,000 | |||||
Interest rate | 8.49% | |||||
Proceeds from notes payable - non-related parties | $ 3,000,001 |
COMMON STOCK (Details Narrative
COMMON STOCK (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |||
Sep. 30, 2022 | May 18, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Public offering, shares sold, shares | 5,120,000 | 2,352,942 | |||
Common stock, shares sold, amount | $ 4,054,055 | $ 8,700,000 | |||
Description of common stock rounding provision | The Company issued 1,012 shares of common stock in connection with the rounding provision of the 1-for-3 reverse stock split effective in 2022 | ||||
Public offering price | $ 1.48 | $ 4.25 | |||
Common stock, shares sold, shares | 2,128,378 | 2,352,942 | |||
Warrant exercise price | $ 0.001 | $ 0.001 | |||
Issued shares of common stock for service, Value | $ 0 | $ 864,500 | |||
Issuance of new stock, PIPE Offring | 1,925,677 | ||||
Stock Option [Member] | |||||
Common Stock Shares Issued For Services, Shares | 12,329 | ||||
Exercise Price | $ 0.79026 | ||||
Common Stock Shares Issued | $ 48,106 | ||||
Non-Prefunded Warrant [Member] | |||||
Exercise Price | $ 1.35 | ||||
Prefunded Warrant [Member] | |||||
Exercise Price | $ 1.35 | ||||
PIPE [Member] | |||||
Common Stock Shares Issued For Services, Shares | 2,128,378 | ||||
Exercise Price | $ 0.001 | ||||
RSUs [Member] | |||||
Common Stock Shares Issued For Services, Shares | 235,000 | 191,919 | |||
Underwritten Public Offering [Member] | |||||
Common Stock Shares Issued For Services, Shares | 1,647,564 | ||||
Exercise Price | $ 2.125 | ||||
2023 Debt Offering | |||||
Debt conversion, converted instrument, shares issued, shares | 150,000 | ||||
RSUs Vested [Member] | |||||
Common Stock Shares Issued For Services, Shares | 175,252 | 16,667 | |||
Professional Services [Member] | |||||
Common Stock Shares Issued For Services, Shares | 75,000 | ||||
Exercise Price | $ 0.94 | ||||
Issued shares of common stock for service, Value | $ 70,500 | ||||
Convertible Note Payable [Member] | |||||
Common Stock Shares Issued For Services, Shares | 7,917 | ||||
Issued shares of common stock for service, Value | $ 47,500 | ||||
Consultant [Member] | Strategic Advisory And Digital Marketing Services [Member] | |||||
Common Stock Shares Issued For Services, Shares | 500,000 | ||||
Issued shares of common stock for service, Value | $ 455,000 | ||||
Exercise price | $ 0.91 | ||||
Consultant [Member] | Business Development Consulting Services [Member] | |||||
Common Stock Shares Issued For Services, Shares | 300,000 | ||||
Issued shares of common stock for service, Value | $ 264,000 | ||||
Exercise price | $ 0.88 | ||||
Consulting Services [Member] | |||||
Common Stock Shares Issued For Services, Shares | 27,500 | ||||
Exercise Price | $ 2.73 | ||||
Issued shares of common stock for service, Value | $ 75,000 | ||||
Investor [Member] | |||||
Common Stock Shares Issued For Services, Shares | 225,000 | ||||
Series B Convertible Preferred stock | |||||
Common Stock Shares Issued For Services, Shares | 3,000,000 | 1,000,000 | |||
Debt conversion, converted instrument, shares issued, shares | 1,000,000 | 3,000,000 |
PREFERRED STOCK (Details Narrat
PREFERRED STOCK (Details Narratve) - $ / shares | 1 Months Ended | 12 Months Ended | ||||
Dec. 09, 2019 | Apr. 20, 2023 | Nov. 20, 2015 | Dec. 31, 2023 | Dec. 31, 2022 | Mar. 01, 2022 | |
Preferred stock, share Issued | 0 | 0 | ||||
Preferred Stock, Shares Authorized | 25,000,000 | 16,300,000 | 16,300,000 | |||
Preferred Stock, Par Value | $ 0.00001 | $ 0.00001 | ||||
Series A Convertible Preferred stock [Member] | ||||||
Preferred stock, share Issued | 0 | 0 | ||||
Preferred Stock Conversion Description | Series A Convertible Preferred Stock are convertible at a 35% discount rate to the average closing price per share of the Company’s common stock (either as listed on a national exchange or as quoted over-the-market) for the last 15 trading days immediately prior to conversion. However, no conversions of the Series A Convertible Preferred Stock to shares of common stock can occur unless the average closing price per share | |||||
Preferred Stock, Shares Authorized | 3,000,000 | 3,000,000 | 3,000,000 | |||
Preferred Stock, Par Value | $ 0.00001 | $ 0.00001 | $ 0.00001 | |||
Minimum Conversion Rate | $ 5.01 | |||||
Series B Convertible Preferred stock | ||||||
Preferred stock, share Issued | 0 | 3,000,000 | 3,000,000 | |||
Preferred Stock, Shares Authorized | 3,000,000 | 3,000,000 | 3,000,000 | |||
Preferred Stock, Par Value | $ 0.00001 | $ 0.00001 | ||||
Preferences And Rights Of Preferred Stock | (a) dividends shall not be mandatory or cumulative, (b) liquidation preference over the Company’s common stock at an amount per share equal to the original issue price of the Series B Convertible Preferred Stock plus all accrued but unpaid dividends on the Series B Convertible Preferred Stock, (c) each three shares of Series B Convertible Preferred Stock shall be convertible, at the option of the holder, beginning on the date that is six months from the date the Holder acquired the shares of Series B Convertible Preferred Stock, and without the payment of additional consideration by the holder , into one share of common stock, (d) no redemption rights by the Company, (e) no call rights by the Company, and (f) each share of Series B Convertible Preferred Stock will vote on an “as converted” basis | |||||
Exchange shares issued of common stcok | 3,000,000 | |||||
Common stock held by company | 1,000,000 | |||||
Series A-1 Convertible Preferred stock [Member] | SOBR's Director company [Member] | Series A-1 Preferred Stock Purchase Agreement [Member] | SOBR SAFE, LLC [Member] | ||||||
Preferred Stock, Shares Authorized | 2,000,000 | |||||
Authorized Shares Increased | 2,700,000 | |||||
Right Of Dividend | 8% | |||||
Preferences And Rights Of Preferred Stock | (a) dividend rights of 8% per annum based on the original issuance price of $1 per share, (b) liquidation preference over the Company’s common stock, (c) conversion rights into shares of the Company’s common stock at $3 per share (not to be affected by any reverse stock split in connection with the Asset Purchase Agreement with IDTEC), (d) redemption rights such that we have the right, upon 30 days written notice, at any time after one year from the date of issuance, to redeem all or part of the Series A-1 Convertible Preferred Stock for 150% of the original issuance price, (e) no call rights by the Company, and (f) each share of Series A-1 Convertible Preferred Stock will vote on an “as converted” basis |
STOCK WARRANTS STOCK OPTIONS _3
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details) - Warrants [Member] - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Dividend yield | 0% | 0% |
Minimum [Member] | ||
Exercise Price | $ 1.35 | $ 1.35 |
Risk free interest rate | 4.56% | 2.45% |
Expected Term | 3 years | 1 year |
Volatility | 162% | 110% |
Maximum [Member] | ||
Exercise Price | $ 2.52 | $ 6 |
Risk free interest rate | 4.73% | 4.62% |
Expected Term | 5 years | 7 years |
Volatility | 209% | 160% |
STOCK WARRANTS STOCK OPTIONS _4
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details 1) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Outstanding at ending of period | 1,692,473 | 1,103,583 |
Weighted Average Exercise Price Per Share, Warrants exercised | $ 0.79 | |
Weighted Average Remaining Contractual Life, Beginning balance | 5 years 3 months 29 days | 6 years 2 months 15 days |
Weighted Average Remaining Contractual Life, Ending balance | 5 years 7 months 28 days | 5 years 3 months 29 days |
Aggregate Intrinsic Value, Beginning balance | $ 0 | $ 5,804,517 |
Aggregate Intrinsic Value, Ending balance | $ 0 | $ 0 |
Warrants [Member] | ||
Outstanding at beginning of period | 10,387,877 | 836,464 |
Warrants Granted | 611,998 | 13,375,461 |
Warrants Exercised | (3,775,942) | |
Warrants Expired | 394,167 | (48,106) |
Outstanding at ending of period | 10,605,708 | 10,387,877 |
Exercise Price Per Share, Warrants Expired | $ 3.118 | |
Weighted Average Exercise Price Per Share, Beginning balance | $ 1.56 | 6.78 |
Weighted Average Exercise Price Per Share, Warrants granted | 2.09 | 1.94 |
Weighted Average Exercise Price Per Share, Warrants exercised | 0.88 | |
Weighted Average Exercise Price Per Share, Warrants expired | 8.02 | 3.118 |
Weighted Average Exercise Price Per Share, Ending balance | $ 1.70 | $ 1.56 |
Weighted Average Remaining Contractual Life, Beginning balance | 5 years 1 month 9 days | 3 years 14 days |
Weighted Average Remaining Contractual Life, Warrants Granted | 3 years 4 months 20 days | 4 years 4 months 17 days |
Weighted Average Remaining Contractual Life, Warrants Exercised | 0 years | |
Weighted Average Remaining Contractual Life, Ending balance | 4 years 7 months 2 days | 5 years 1 month 9 days |
Aggregate Intrinsic Value, Beginning balance | $ 0 | $ 1,784,838 |
Aggregate Intrinsic Value, Warrants granted | 0 | 0 |
Aggregate Intrinsic Value, Warrants Expired | 0 | |
Aggregate Intrinsic Value, Ending balance | $ 0 | $ 0 |
Minimum [Member] | Warrants [Member] | ||
Exercise Price Per Share, Beginning balance | $ 1.35 | $ 1.50 |
Exercise Price Per Share, Warrants granted | 1.35 | 1.35 |
Exercise Price Per Share, Warrants Exercised | 0.001 | |
Exercise Price Per Share, Warrants Expired | 2.56 | |
Exercise Price Per Share, Ending balance | 1.35 | 1.35 |
Maximum [Member] | Warrants [Member] | ||
Exercise Price Per Share, Beginning balance | 9 | 9 |
Exercise Price Per Share, Warrants granted | 2.52 | 5.3125 |
Exercise Price Per Share, Warrants Exercised | 2.125 | |
Exercise Price Per Share, Warrants Expired | 9 | |
Exercise Price Per Share, Ending balance | $ 5.31 | $ 9 |
STOCK WARRANTS STOCK OPTIONS _5
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details 2) - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Stock Options [Member] | Minimum [Member] | ||
Exercise Price | $ 0.48 | $ 1.54 |
Risk free interest rate | 4.09% | 0.78% |
Expected Term | 1 year | 1 year |
Volatility | 143% | 89% |
Stock Options [Member] | Maximum [Member] | ||
Exercise Price | $ 2.16 | $ 9.075 |
Risk free interest rate | 5.04% | 4.01% |
Expected Term | 6 years | 3 years |
Volatility | 207% | 192% |
Stock Option [Member] | ||
Dividend yield | 0% | 0% |
STOCK WARRANTS STOCK OPTIONS _6
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details 3) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Outstanding at beginning of period | 1,103,583 | 1,053,356 |
Options Granted | 1,075,000 | 120,000 |
Options Exercised | (48,106) | |
Options Expired/Forfeited | (486,110) | (21,667) |
Outstanding at ending of period | 1,692,473 | 1,103,583 |
Option outstanding number of shares exercisable | 1,014,828 | 930,573 |
Exercise Price per Share, Options Exercised | $ 0.79 | |
Weighted Average Remaining Contractual Life , Beginning balance | 5 years 3 months 29 days | 6 years 2 months 15 days |
Weighted Average Remaining Contractual Life, Options Granted | 4 years 1 month 2 days | 3 years 5 months 1 day |
Weighted Average Remaining Contractual Life, ending balance | 5 years 7 months 28 days | 5 years 3 months 29 days |
Weighted Average Remaining Contractual Life, exercisable | 4 years 4 months 9 days | 5 years 9 months 29 days |
Weighted Average Exercise Price Per Share, Beginning balance | $ 1.71 | $ 3.40 |
Weighted Average Exercise Price Per Share, Options granted | 1.17 | 5.79 |
Weighted Average Exercise Price Per Share, Options exercised | 0.79 | |
Weighted Average Exercise Price Per Share, Options Expired/Forfeited | 1.19 | 9.33 |
Weighted Average Exercise Price Per Share, ending balance | 2.01 | 1.71 |
Weighted Average Exercise Price Per Share Exercisable | $ 2.14 | $ 1.60 |
Aggregate Intrinsic Value, Beginning balance | $ 0 | $ 5,804,517 |
Aggregate Intrinsic Value, Options exercised | 0 | 0 |
Aggregate Intrinsic Value, Options granted | 0 | 0 |
Aggregate Intrinsic Value, Options expired forfeited | 0 | 0 |
Aggregate Intrinsic Value, Ending balance | 0 | 0 |
Aggregate Intrinsic Value, exercisable | $ 0 | $ 0 |
Options Exercised Exercise Price Per Share | $ 0 | $ 0 |
Stock Options [Member] | Minimum [Member] | ||
Exercise Price Per Share, Beginning balance | 0.79 | 0.79 |
Options Granted | 0.48 | 1.54 |
Options Expired/Forfeited | 0.79 | 4.94 |
Exercise Price Per Share, Ending balance | 0.48 | 0.79 |
Exercise Price Per Share Exercisable, Ending balance | 0.48 | 0.79 |
Stock Options [Member] | Maximum [Member] | ||
Exercise Price Per Share, Beginning balance | 9.30 | 10.74 |
Options Granted | 2.32 | 9.08 |
Options Expired/Forfeited | 2.39 | 10.73 |
Exercise Price Per Share, Ending balance | 9.30 | 9.30 |
Exercise Price Per Share Exercisable, Ending balance | $ 9.30 | $ 9.30 |
STOCK WARRANTS STOCK OPTIONS _7
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details 4) - Restricted Stock Units [Member] | 12 Months Ended |
Dec. 31, 2023 $ / shares shares | |
Unvested Beginning | shares | 380,000 |
Granted | shares | 148,080 |
Vested | shares | (315,000) |
Unvested Ending | shares | 213,080 |
Weighted Average Grant Date Fair Value Per Share Beginning balance | $ / shares | $ 2.17 |
Weighted Average Grant Date Fair Value Per Share RSU Granted | $ / shares | 1.18 |
Weighted Average Grant Date Fair Value Per Share Rsu Vested | $ / shares | 1.90 |
Weighted Average Grant Date Fair Value Per Share Ending balance | $ / shares | $ 1.88 |
Weighted Average Vesting Period Restricted Stock Unit, beginning | 8 months 26 days |
Weighted Average Vesting Period Restricted Stock Unit, Granted | 1 year 7 months 6 days |
Weighted Average Vesting Period Restricted Stock Unit, Ending | 1 year 8 months 26 days |
STOCK WARRANTS STOCK OPTIONS _8
STOCK WARRANTS STOCK OPTIONS AND RESTRICTED STOCK UNITS (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |||||||||
Nov. 04, 2022 | Jan. 31, 2023 | Mar. 30, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Nov. 10, 2023 | Aug. 04, 2023 | Feb. 23, 2023 | Jan. 07, 2022 | Jan. 01, 2022 | Oct. 24, 2019 | |
Stock based compensation expense | $ 2,245,871 | $ 3,008,395 | |||||||||
Restricted Stock Units [Member] | |||||||||||
Granted | 148,080 | ||||||||||
Unrecognized compensation expense | $ 124,190 | ||||||||||
Weighted avaerage unrecognized compensastion cost | 24 months | ||||||||||
Stock based compensation expense | $ 641,043 | 1,426,178 | |||||||||
Fair value of RSUs granted | $ 174,062 | $ 1,112,725 | |||||||||
Unvested RSUs granted to executive officers | 98,080 | 200,000 | |||||||||
RSUs outstanding executive officers | 437,372 | 537,371 | |||||||||
Weighted average remaining contractual life | 7 years 6 months 3 days | 5 years | |||||||||
Remaining weighted average vesting period | 24 months | 5 months | |||||||||
Restricted Stock Units [Member] | Executive Officer [Member] | |||||||||||
Granted | 148,080 | 281,667 | |||||||||
Restricted Stock Units [Member] | Director [Member] | |||||||||||
Granted | 140,000 | ||||||||||
Restricted Stock Units [Member] | Employment Agreement With Jerry Wenzel [Member] | |||||||||||
Stock options to acquire shares of common stock | 66,667 | ||||||||||
Vested option shares | 66,667 | ||||||||||
Exercise price | $ 2.387 | $ 8.25 | |||||||||
Common stock issued for RSUs vested | 75,000 | 125,000 | 50,000 | 16,667 | |||||||
Weighted average fair value of RSU per share | $ 2.17 | $ 0.48 | |||||||||
Restricted Stock Units [Member] | Employment Agreement With David Gandini [Member] | |||||||||||
Stock options to acquire shares of common stock | 510,000 | ||||||||||
Exercise price | $ 2.32 | ||||||||||
Common stock issued for RSUs vested | 50,000 | 98,080 | |||||||||
Weighted average fair value of RSU per share | $ 1.53 | ||||||||||
Minimum [Member] | Restricted Stock Units [Member] | Executive Officer [Member] | |||||||||||
Exercise price | $ 0.7902 | $ 0.7902 | |||||||||
Maximum [Member] | Restricted Stock Units [Member] | Executive Officer [Member] | |||||||||||
Exercise price | $ 2.387 | $ 2.387 | |||||||||
Stock Options [Member] | |||||||||||
Stock options to acquire shares of common stock | 1,692,473 | 1,086,813 | |||||||||
Vested option shares | 29,900 | 1,014,828 | 930,573 | ||||||||
NonVested option shares | 677,645 | 173,009 | |||||||||
Description of exercise prices | exercise prices ranging from $8.25 - $10.56 to be repriced at 110% ($2.39) and 100% ($2.17) of the current price | ||||||||||
Fair value of the options increased | $ 55,859 | ||||||||||
Unrecognized compensation expense | $ 1,786 | $ 1,138,937 | |||||||||
Stock options shares | 305,000 | ||||||||||
Stock based compensation expense | $ 1,604,827 | $ 1,582,217 | |||||||||
Stock Options [Member] | Minimum [Member] | |||||||||||
Weighted avaerage unrecognized compensastion cost | 3 months | 5 months | |||||||||
Stock Options [Member] | Maximum [Member] | |||||||||||
Weighted avaerage unrecognized compensastion cost | 9 months | 34 months | |||||||||
Stock Warrant [Member] | |||||||||||
Fair value of warrant | $ 864,000 | $ 560,998 | $ 27,540,584 | ||||||||
Common stock purchase | 101,626 | ||||||||||
Exercise price warrant decrease | $ 1.35 | ||||||||||
Number of authorized shares | 1,733,333 | ||||||||||
Authorization of shares of common stock | 3,500,000 | 1,282,823 | |||||||||
Stock Warrant [Member] | Consulting Agreement [Member] | |||||||||||
Common stock, shares issued | 225,000 | ||||||||||
Number of warrants to purchase common stock | 225,000 | ||||||||||
Exercise price | $ 1.35 | ||||||||||
Derscription | underwritten public offering 4,705,884 Offering Warrants, 424,116 Underwriter Warrants, and 141,177 Representative Warrants to purchase common stock of the Company at exercise prices of $4.25, $4.25 and $5.3125 per share, respectively. The warrants expire five years from the date of issuance and were valued using the Monte Carlo simulation option pricing model at approximately $5,700,000. The exercise price on the Offering Warrants and Underwriter Warrants was reduced to $2.125 per share in September 2022 in accordance with a down-round provision contained in those warrants | ||||||||||
Warrants outstanding | 3,623,613 | ||||||||||
Fair value of warrant | $ 162,481 | ||||||||||
Debt [Member] | |||||||||||
Number of warrants to purchase common stock | 386,998 | ||||||||||
Fair value of warrant | $ 398,517 | ||||||||||
Common stock share price | $ 2.52 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) | Dec. 31, 2023 | Dec. 06, 2006 |
COMMITMENTS AND CONTINGENCIES | ||
Accrued liabilities amount | $ 11,164 | |
Accrued Interest | $ 19,000 | |
Lawsuit amount | $ 11,164 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Net loss | $ (10,214,704) | $ (12,354,913) |
Net Provision For Income Tax | 0 | 0 |
Federal Income Tax [Member] | ||
Net loss | (10,214,704) | (12,354,930) |
Permanent Differences | 2,382,227 | 1,732,832 |
Valuation Allowance | 7,832,477 | 10,622,098 |
Net Provision For Income Tax | $ 0 | $ 0 |
INCOME TAXES (Details 1)
INCOME TAXES (Details 1) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Net Operating Loss Carry Forward | $ 39,824,000 | |
Federal [Member] | ||
Net Operating Loss Carry Forward | 7,723,005 | $ 5,759,000 |
Valuation Allowance | (7,723,005) | (5,759,000) |
Net Deferred Tax Asset | 0 | 0 |
State [Member] | ||
Net Operating Loss Carry Forward | 1,991,222 | 1,524,000 |
Valuation Allowance | (1,991,222) | (1,524,000) |
Net Deferred Tax Asset | $ 0 | $ 0 |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
INCOME TAXES | ||
Deferred Tax Asset | $ 9,714,000 | $ 7,283,000 |
Change In The Valuation Allowance | $ 2,429,000 | $ 3,154,000 |
Rate Of Net Operating Losses Offset By Valuation Allowance | 100% | 100% |
Federal Tax Rate | 21% | 21% |
Description of loss | net operating loss carry-forwards of approximately $39,824,000 that will be carried forward and can be used through the year 2028 | |
Net Operating Loss Carry Forward | $ 39,824,000 | |
State Tax Rate | 5% | 5% |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($) | Mar. 06, 2024 | Mar. 04, 2024 | Mar. 05, 2024 |
Conversion amount of common stock | $ 804,695 | ||
Debt offering shares | 1,297,895 | ||
Common stock, shares par value | $ 0.62 | ||
Description of warrants purchase | the exercise prices for Common Stock Purchase Warrants issued on September 30, 2022, in relation to the PIPE Offering and Common Stock Purchase Warrants issued on March 9, 2023 related to the 2023 Debt Offering were permanently reduced to $0.62 per share | ||
Description of Armistice warrants | the Company issued an aggregate 2,659,031 warrants (the “Armistice Warrants”) consisting of (i) 2,127,225 warrants pursuant to the Adjustment terms under the September 2021 Armistice Warrant, and (ii) 531,806 warrants pursuant to the Adjustment terms of the March 2022 Armistice Warrant | ||
Exercise price | $ 1.35 | ||
Warrant exercise price | 1.35 | ||
Permanently Warrant exercise price | $ 0.62 |